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Cells within the body experience a wide range of dynamic mechanical stimuli. These stimuli are 
exacerbated in cancers and can alter the progression of the disease. As the tumor grows and expands, it 
presses out against the surrounding matrix and cell environment, creating internal compressive forces. The 
growing tumor also alters interstitial and vascular blood flow thereby enhancing shear stress exposure. How 
cells translate this mechano-environment into downstream signaling is known as mechanotransduction. 
Though preliminary research has touched on the influence physiological mechanical stimulus can have on 
cancer progression, the work remains erratic on cell metastasis, gene expression, proliferation, and 
chemotherapeutic response. In order to address this unknown effect on cellular phenotypes and treatment 
response, two bioreactors capable of tunable three-dimensional stimulus with either shear stress or 
compressive stress were developed. Breast and ovarian cancer cells were first encapsulated within a 3D 
combination agarose/collagen-I hydrogel and then exposed to physiological mechanical stimuli relevant to 
the unique microenvironments of pleural effusions and ascitic environment respectively for 24 to 72 hours. 
Stimulated cells were then assessed for morphological alterations, altered gene expression (RT-qPCR), 
proliferation (ki67 expression), and drug resistance via standard chemotherapeutic treatment (cell death via 
casp-3 expression). Breast cancer cells exposed to varying levels of shear stimulus occurring within the 
pleural effusion microenvironment showed stimulus aided in cancer cell proliferation, invasive potential, 
and survival in the presence of paclitaxel treatment concurrent with the activation of the PLAU and COX2 
pathways. Next, ovarian cancer cells were subjected to compressive forces found within the solid tumor 
microenvironment and as consequence of the hydrostatic pressure caused via ascitic fluid retainment. 
Ovarian cancer proliferation, morphological elongation, and enhanced survival was observed under 




Finally, ovarian cancer cells were stimulated with shear stresses representative of ascitic fluid buildup in 
the peritoneal cavity in ovarian cancer patients. This shear stress conditioning altered cellular morphology, 
enhanced proliferation as well as chemoresistance to dual chemotherapeutic drug treatment with paclitaxel 
and carboplatin. This alteration in cellular phenotype was found alongside consistent downregulation of 
MUC15, a potential protein of interest for future mechanotransduction studies.  
Overall, findings suggest that this dynamic mechanical environment aids in the advancement of 
cancer migration, proliferation, and chemoresistance which may be mitigated by targeting various 
mechanotransduction pathways. This is the first reported tie of shear stress stimulation to PLAU and COX2 
pathway activation in breast cancer. Additionally, this is the first time mechanotransduction has been tied 
to CDC42 activation and MUC15 downregulation in ovarian cancer. The bioreactors constructed and 
utilized for this study provide 3D platforms ideal for understanding the influence of compressive and shear 
stress stimulus on cellular behavior, a critical component to our understanding and improvement of cancer 






1.1 Introduction to Cancer and the Tumor Microenvironment 
Cancer is the second leading cause of death in the United States with a predicted diagnosis of over 1.7 
million new cases each year1. One out of every three people is predicted to develop some form of invasive 
cancer within their lifetime, making it a widespread and highly relevant disease to human health. Cancer is 
defined as a group of aberrant cells that proliferate uncontrollably and is categorized by cell type and stage 
of the disease, which indicates dispersal throughout the body. Cancer response rates to treatments vary 
extensively depending on cancer type, stage of the disease, and patient-specific attributes. These variables 
make cancer research a complex and convoluted system to study. Where the tumor resides is known as the 
tumor microenvironment, consisting of the surrounding cells, blood and lymphatic vessels, extracellular 
matrix (ECM), soluble signaling factors, immune interactions and a variety of mechanical stimuli. All these 
factors contribute to the maintenance and progression of the disease influencing metastasis and treatment 
responses of patients2. Therefore, it is imperative that we study the relationship of cancer types and these 





Figure 1: Components of the tumor microenvironment. 2 
A. To develop an accurate multi-dimensional understanding of the structure, organization, and 
complex relationships in cancers, we need to consider the following factors. Heterogeneous cancer 
cells reside in a complex tumor microenvironment, which consists of mechanical stimuli, non-
malignant cell-cancer cell interactions, soluble signals, and extracellular matrix (ECM). The 
dimensionality of cell culture influences cancer cell motility and cellular interaction with the 
surrounding cells and ECM. Mechanical stimuli including shear, compressive, tensile, and 
viscoelastic forces, dynamically influence cancer cells as the tumor grows. Similarly, cellular 
interactions through direct contact with surrounding non-malignant cells and soluble signals alter 
communication and downstream signaling. Interactions between immune cells and cancerous cells 
are highly complex and can lead to immune evasion and support of tumor progression. All of these 
characteristics play an integral role in tumor progression and are critical to forming a complete 
picture of the cancer system. 
B. The mechanical forces acting within the tumor microenvironment.  
 
1.2 Mechanical Forces within the Tumor Microenvironment 
Within the tumor microenvironment cells are subjected to a variety of forces. They experience a range of 
compression, tension, shear stress, and stiffness as do the normal cells within our body. How these forces 
are interpreted and converted into downstream signaling cascades and phenotypic responses is known as 
mechanotransduction. As a tumor forms and grows, it is both the cause and recipient of aberrant mechanical 
stimuli. The growing mass presses out against the native cells and surrounding matrix, creating compressive 




circumferential strain, due to the inner expansion of the mass. Much like the walls of a balloon are stretched 
when the interior expands, the cancer cells that line the interface of the tumor are strained while 
simultaneously experiencing the compressive pressure from the surrounding ECM. The fluid movement 
cells experience originates from interstitial fluids as well as lymphatic and blood flows. This fluid exchange 
is significantly altered within and surrounding the tumor, and this change creates irregular flow patterns 
and altered shear stress stimulus. The level of shear stress experienced by cells heavily depends on the 
tumor microenvironment. Specifically, metastatic sites such as pleural effusions, ascitic build up, and 
circulating tumor cells within the vasculature can experience shear stresses up to 60 dynes/cm2 or greater.  
In addition to these forces, the matrix in which tumor cells grow undergoes dynamic stiffness changes with 
the progression of the disease. The body creates scar-like or fibrous tissue surrounding the cancer, which 
alters the perceived stiffness of the microenvironment by the cancer cells. These dynamic stimuli and 
perceived forces all influence attributes of the disease such as metastasis, proliferation, chemoresistance, 
and gene expression; these characteristics can alter patient outcomes. As one can imagine, the location 
within the body and microenvironment factors dictate the magnitude of these forces and the cell types 
exposed. Therefore, it is crucial to elucidate cancer types and conditions prior to the development of devices 
that target the study of these forces. Here I will describe the unique microenvironments of breast and ovarian 
cancers for mechanotransduction investigations into shear and compressive stress stimulus.  
1.3  The Microenvironment of Breast Cancer Pleural Effusions 
Breast cancer is the second leading cause of cancer-related death and the primary form of newly diagnosed 
cases in U.S. females. It accounts for nearly forty-one thousand deaths each year across the nation1. The 
overall death rate due to breast cancer has been decreasing by 1.8% each year since 1998, but our work is 
not done. When diagnosed at early stages, in which the cancer remains localized or regional, the five-year 
survival for patients is very good (76-99%)3. Those who are diagnosed with distant spread of the disease 
only have a 27% survival rate. These poor survival rates emphasize the need for late stage breast cancer 




Breast cancer patients have a 50% likelihood of developing pleural effusions4, defined as fluid within the 
lung cavity. The pleural membrane lines the inside of the chest wall as well as the exterior of the lung to 
reduce friction and allow for organ movement while breathing. The buildup of fluid within this space 
hinders breathing, causes pain, and stimulates the cancer cells that have metastasized to the area. Breast 
carcinoma causes one third of all malignant pleural effusions5 and patients have a mean survival of 3-36 
months5,6. Targeted treatment for this condition is to remove the fluid and prevent further buildup via 
thoracentesis, tube drainage, catheter placement, or chemical pleurodesis such as talc5. Beyond draining the 
fluid, no true treatment exists for these patients and the development of pleural effusions often marks the 
end stages of the disease5.  
In order to improve patient outcomes and develop new therapies, we must first better understand the 
consequence of this abnormal microenvironment, including the mechanical forces the cells are subjected 
to. It has been predicted that within the pleural space shear forces can reach 60 dynes/cm2, depending on 
breathing rate7. Thus, how breast cancer cells that have infiltrated this space respond to shear stress stimulus 
is important to our understanding and treatment of late stages of this disease.    
1.4 The Unique Microenvironment of Ovarian Cancer 
Ovarian cancer is the fifth leading cause of cancer related deaths in females8 and remains a deadly diagnosis 
with 54%9 of patients dying from their initial or recurrent disease. While significant advancements in 
treatment therapies and success rates have been observed in some cancers, there has been no significant 
progress in ovarian cancer treatment over the past 50 years10,11. Much of this failure arises from the lack of 
early detection capabilities, with 60-70% of all patients diagnosed at advanced stages (III or IV)8,12–15 and 
an 85% recurrence rate16. Ovarian cancer is categorized by cell of origin, with approximately 90% 
originating from epithelial cells. Epithelial ovarian cancer is then classified into histological subgroups 
where the serous subtype makes up 70% of all tumors17. The serous histological subtype is grouped in a 
two-tier system based on the prevalence of mitotic rate and atypical nuclei10,18. 90% of all serous epithelial 




mutations, rapid tumor growth, and high recurrence17,18. The recurrent disease is often chemoresistant and 
has a median survival of 12-24 months16. Many of these statistics arise from factors within the tumor 
microenvironment, therefore, it is critical to consider their role when striving to understand and devise 
treatment strategies to improve patient outcomes.  
Located within the peritoneal cavity, the ovaries exist within the abdominal space where cellular and 
acellular contents are tightly regulated by the anatomy of the peritoneal membrane. The peritoneal 
membrane consists of five layers: endothelial cells, endothelial basement membrane, interstitial space, 
submesothelial basement membrane, and mesothelial cells19. These tight layers inhibit cells and large 
protein molecules, such as albumin, from migrating into the peritoneal cavity. In healthy individuals, the 
peritoneal membrane modulates a net oncotic pressure out of the cavity19 filtering 50-100 mL of fluid to 
the lymphatic vessels every hour20. However, this tight regulation is not upheld in ovarian cancer patients 
that develop ascites. Epithelial ovarian cancers arise from either an ovarian surface epithelium stem cell or 
fimbrial stem cell that becomes entrapped within the ovary cortex. This entrapped cell then forms a cortical 
inclusion cyst that is driven to high-grade serous carcinoma from the aberrant niche environment10,17,21.  
It is not uncommon for healthy individuals to have fluid formation within the peritoneal cavity. Healthy 
post-menopausal women will carry an average of 2.3 mL of intraperitoneal fluid at any given time22. Fluid 
in the peritoneal cavity is constantly spreading and following preexisting routes within the intraperitoneal 
space. This natural flow is generated by gravity and negative intra-abdominal pressures23. However, in a 
diseased state, this intraperitoneal fluid is not readily drained. A backup of liquid, termed ascites, may begin 
to amass in some patients. Approximately 36.7% of all ovarian cancer patients develop ascites24–26, defined 
as a minimum of 25 mL of fluid accumulation27 within the peritoneal cavity. The retention of ascitic fluid 
in diseased patients, stems from an increase in the permeability of the capillaries through the peritoneal 
membrane, lymphatic obstruction of normal drainage, as well as a net oncotic pressure of zero within the 
cavity19,20,28,29. Ovarian cancer cells and cellular aggregates that are shed into the peritoneal cavity can 




metastases are an integral part of ascites formation in ovarian cancers, has been around for more than 60 
years28,31,32. Yet, the exact mechanisms involved in the production of excess peritoneal fluid are still 
unclear29. Detection of ovarian cancer within the peritoneal cavity is associated with most stages of ovarian 
cancer. According to the American Joint Committee on Cancer (AJCC) and International Federation of 
Gynecology and Obstetrics (FIGO), stages IC, IIB, III, and IV ovarian cancers are all categorized by the 
presence of cancer in the peritoneal33,34. The detection of malignant ascites is an integral step in the clinical 
assessment of ovarian cancer35.  Furthermore, malignant ascitic fluid is a major contributor to ovarian cancer 
progression and poor prognoses29, and is consequently closely monitored by oncologists. 
The presence of ascitic fluid has been shown to aid in metastasis36 and chemoresistance37,38. It also 
mechanically stimulates the cancer with hydrostatic compression and shear forces. The ascitic fluid flow is 
triggered by gravity, changes in diaphragmatic pressure from breathing, surrounding organ movement 
aiding digestion, as well as bodily movements like walking39. Therefore, the continuous barrage of turbulent 
fluid flow stimulates a variety of mechanotransduction signaling pathways, and further exfoliates ovarian 
tumor cells and cellular aggregates from the surface epithelium into the peritoneal cavity. After their escape 
into the ascites, these free-floating cancer cells and cellular clusters often self-assemble and aggregate to 
form spheroids, thereby overcoming anoikis30,40, cell death due to loss of adherence to surroundings. Once 
ovarian cancer cells have disseminated within the ascites, they have access to the most common metastatic 
sites of ovarian cancers: the peritoneum, the greater omentum, the right subphrenic region, the lung, and 
liver23,39,40. The presence of ascites and forces associated with them facilitate transcoelomic metastasis, the 
most common form of ovarian cancer metastasis36,39. Figure 2 details the mechanical forces relevant to 





Figure 2: Mechanism of transcoelomic metastasis in ovarain cancer and relevant mechanical forces.41 
A. Transcoelomic metastasis starts with the exfoliation and detachment of cancer cells from the 
primary tumor site caused by shear stress within the ascites. Cancer cells within ascites evade the 
immune system and detached cells form spheroids to avoid anoikis. Ovarian cancer spheroids are 
then carried by the ascitic current to metastatic sites where implantation, invasion, and growth 
facilitate the formation of new tumors.   
B. The buildup of ascites is triggered by the primary tumor which causes increased capillary 
permeability, lymphatic obstruction of drainage, and an overall decrease in oncotic pressure out 




C. The ovarian cancer cells experience the surrounding ECM stiffness within the primary tumor, 
spheroid cell aggregates within the ascites, and potential metastatic sites. Shear stress stimulates 
the ovarian cancer cells via interstitial fluid flow within the primary tumor and ascitic fluid flow 
triggered by gravity, bodily movements, change in diaphragmatic pressure from breathing, and 
organ movements from things such as digestion. Compressive forces act on the primary tumor by 
the growth induced stress as well as hydrostatic pressure from the ascites.  
  
Compression is unique for ovarian cancer as it is caused by two primary sources (Figure 1B, Figure 2C). 
The first of these is growth-induced stress, stemming from the aberrant cell proliferation and displacement 
of the native cell populations. The stress induced from this form of growth is estimated to range between 
4.7-18.9 kPa in human tumors and 0-1.3 kPa for avascular tumor spheroids via experimental data and 
mathematical models42. The studies by Jain et al. suggest that external stress, stemming from the native 
tissue, is a more noteworthy contributor to total perceived stress, as compared to the compressive stress 
from tumor growth that accounts for less than 30% of total solid stress of a tumor.  In addition to growth-
induced stress, the presence of excess fluid and ascites create hydrostatic pressure. This adds to the 
compressive forces experienced by ovarian cancer cells43, although the contribution to compression is 
highly variable between patients and is dependent on volume of ascitic fluid.  In light of these findings, it 
is evident that compression greatly influences ovarian cancer mechanobiology.   
Ovarian cancer cells isolated from ascites are enriched in cancer stem cells (CSCs)44,45. CSCs are defined 
as a small subset of cancer cells, with the capability of self-renewal, multilineage differentiation, tumor 
initiation, metastasis, and chemoresistance to conventional or targeted chemotherapies and radiotherapies. 
Ovarian CSCs, or side population cells, are typically identified through expression of specific markers such 
as CD133, ALDH1A, CD24, CD117, CD4446–49, miRNA expression, as well as, functional phenotypes such 
as self-renewal, the production of heterogeneous descendants, and enhanced tumor formation capabilities46. 
CSCs are typically enriched after chemotherapy as residual cells that lead to tumor relapse in patients. The 
presence of ascites increases the drug efflux mechanisms within the ovarian cancer cells including ABC 
transporter genes: MDR1a, MDR1b, BCRP44,50. The upregulation of these transporter genes provides 




treatment. Additionally, ascites have been shown to enhance EMT in ovarian cancer cells15,51,52. During 
EMT, a stationary epithelial cell transforms to a mesenchymal cell capable of motility. This transition is an 
important precursor to metastasis and chemoresistance53,54. Currently, the role of the mechanical cues within 
ovarian tumor microenvironment towards these outcomes is not well defined. Therefore, the effects of 
mechanotransduction in the ovarian cancer microenvironment need to be investigated in the context of 
disease progression and chemoresistance. It is likely that future findings could greatly improve patient 
treatment and outcome.  
1.5 Current models for Investigating the Influence of Mechanical Stimuli and their Findings 
In order to systematically investigate the impact of these mechanical forces on cellular responses, 
researchers develop in vitro devices for controlled cancer models41,42,55,56 37,57–60.  Tension within the tumor 
microenvironment (TME) is often replicated via microreactors with flexible membranes simulate 
stretching. Stretching using the microreactor models has been shown to promote cancer cell growth and 
induce proliferation57,61,62, as well as upregulation of the YAP/TAZ pathways61. Commercially available 
bioreactors provide varying levels of uniaxial or equiaxial tensile force63.  
The surrounding tissue provides resistance to the expanding tumor. As a consequence, the tumor is exposed 
to high levels of solid stress and the cancer cells experience ever increasing compressive force64–66. 
Scaffolds to study cancer compressive mechanotransduction have been fabricated using poly(lactide-co-
glycolide) or hyaluronic acid, seeded with cells, and exposed to cyclic loading via compression 
bioreactors67,68. These bioreactors are typically designed and built in-house to allow for fine-tuned 
compressive loading cycles, although commercial options do exist. As a variation to this approach, cells 
can be embedded in a hydrogel and exposed to static compression by using a weight or piston to achieve 
the desired force60,69–71.  
The role of TME stiffness on cancer phenotype has been studied with a variety of models. For example, 
surface functionalized PDMS microposts have been  engineered for specific stiffness and used to evaluate 




concentration of hydrogels during fabrication also modulates the hydrogel’s stiffness. Employing this 
technique allows the effects of stiffness to be tested on cancer cells without changing the substrate to which 
cells adhere58,73–75. Optical tweezers have also been used to study the effects of stiffness of single cancer 
cells76. Dynamic ECM models that replicate the ECM remodeling during cancer progression to support  
tumor growth, are increasingly becoming popular, since they modulate physical properties over time77. 
Most human tissue and polymer or protein ECM analogues experience varying degrees of an elastic strain 
during loading cycles. These viscoelastic matrices show time-dependent recovery when loads are removed. 
In recent years, the viscoelastic nature of the TME has been shown to impact tumor matrix remodeling in 
collagen, fibrin, alginate, reconstituted basement membrane, and agarose hydrogel models78. 
Viscoelasticity has also been shown to impact cancer cell invasion in interpenetrating network hydrogels 
with low molecular weight RGD-alginate and reconstituted basement membrane, as well as collagen type 
I hydrogels79,80. Given the importance of ECM viscoelasticity in cancer progression and metastasis, 
additional studies are required to model and probe viscoelastic changes in the TME.  
In addition, the TME is under a constant barrage of fluid-induced shear stress. Leaky vasculature within the 
tumor niche as well as venous blood flow has been shown to exert shear stresses ranging from 0.5 to 4.0 
dyn/cm2. Circulating tumor cells and metastatic cells undergoing intravasation and extravasation may also 
experience a range of arterial shear stress from 4 to 30 dyn/cm2 81. Shear stress is often tested using a 
microfluidic device design where growth medium is pumped through the closed system using a syringe or 
circulating pump. A narrowing of the flow channel within the device allows for pronounced wall shear 
stress and controlled laminar flow82.  
Shear stress stimulation has been shown to increase proliferation59, upregulate the pro-survival ERK 
pathways83, enhance motility via YAP/TAZ84, and increase chemoresistance37. Parallel plate85 and rotary 
bioreactors86 that apply shear stress to cells have also been used to study adhesion mechanics of tumor cells. 
Perfusion bioreactors typically provide cancer cells with relatively uniform shear stress across the entirety 




or hydrogel. Taken together, there is ample evidence of the significant role that the mechanical forces in 
the TME play in tumor progression and of the variability present between models used to study mechanical 
stimuli. It is clear that mechanical stimuli influence key hallmarks of cancer and that the tumor requires this 
stimulus to elicit specific functionality; however, how cellular processes sense each of these stresses and 
translate them to altered gene expression is still poorly understood. Figure 3 presents some exemplary 
devices currently used for cellular mechanical stimulus.  
 
Figure 3: Representative bioreactors that recapitulate the mechanical forces in cancers. 
A. PDMS tension system designed and fabricated by Ao et al. utilizing a vacuum on the outer wells 
to provide tension to the cell culture system57  
B. Microfluidic shear stress system utilized by Fan et al. to mimic shear stresses experienced by 
circulating human colon cancer cells59.  
C. Shear stress system by Ip et al. investigating ovarian cancer cell stemness response to fluid flow37.  
D. Compression system designed by Demou et al. showing compressive strain enhances metastatic 
potential of glioblastoma and breast cancer cells60.  
E. Cell stretching device from Lam et al. capable of whole cell stiffness analysis72.  
F. Evaluation of mammary cells grown on collagen gels with variable stiffness from Paszek et al.73. 
1.6 Thesis Overview 
The microenvironment in which each cancer resides is uniquely impactful to the cells within it. For this 
reason, careful considerations should be made when studying a specific disease and stimulus. Although 




not specific to the microenvironment of interest. For example, cell cultures in 2D may be used for ease of 
design and imaging capabilities despite the lack of physiological relevance to our 3D selves. To ensure a 
culture and stimulus system capable of capturing relevant aspects of the breast cancer pleural effusions and 
ovarian cancer microenvironments, two independent systems were constructed. The first, a 3D shear stress 
stimulus bioreactor, utilized for breast cancer cell stimulus in Chapters 2 and 3. The second, a 3D 
compression bioreactor for ovarian cancer investigation, is discussed in Chapter 4. Chapter 5 discusses 
improvements and modifications that were made to the shear stress bioreactor design as well as the findings 
resulting from ovarian cancer shear stress stimulus studies. Finally, conclusions and future directions for 




Chapter 287: Fluid Shear Stress Stimulates Breast Cancer Cells to Display Invasive and 
Chemoresistant Phenotypes while Upregulating PLAU in a 3D Bioreactor
2.1  Introduction 
In 2018, breast cancer was the second leading cause of cancer-related death in females accounting for 30% 
of all new cancer diagnosis 1. The progression of the disease is heavily dependent on the mammary tumor 
microenvironment (TME) which is comprised of a variety of dynamic stimuli, including shear, 
compression, tension and the surrounding three dimensional (3D) extracellular matrix (ECM) stiffness 88,89. 
In order to discover effective therapeutics, numerous in vitro models have been developed to isolate and 
explore the role of dynamic 3D stimuli within the TME 90–98. 
Breast cancer cells have been shown to alter their expression and behavior contingent on specialized cues 
originating from the surrounding microenvironment. For instance, it has been demonstrated that breast 
cancer cells show increased invasiveness when cultured in 3D versus 2D substrates 90,94 and promote 
motility, adhesion, and metastasis under shear stress 99–104. Cancer cells within primary tumors, pleural 
effusions, secondary metastasis and the TME experience a wide range of shear stresses. Within the primary 
tumor, interstitial fluid shear stress may be as low as 0.1 dynes cm-2, but cancer cells exposed to vascular 
blood flow can experience fluid shear stress up to 30 dynes cm-2 100,105–108. Interstitial velocity flow has been 
shown to stimulate rheotaxis in breast cancer cells, showing positive migration towards areas of elevated 
shear stress 96,109,110. Breast cancer rheotaxis might be one mechanism guiding malignant tumor cells to 
distant metastatic sites. Fifty percent of all breast cancer patients present pleural effusions 111. Once 
advanced malignancies progress to pleural spaces, the cancer cells experience fluid shear stress ranging 




Furthermore, changes in the extracellular fiber architecture, differences in ECM alignment, and expansion 
of the tumor itself alters the velocity and path of the fluid flow across the stimulated cells 112. A rapidly 
changing TME both modulates and increases interstitial fluid flow over time within a diseased 
microenvironment. The continuous and elevated levels of shear stress present in the breast and malignant 
TME accentuates the importance of investigating the effects of shear forces within cancer progression 
106,112,113.   
The urokinase plasminogen activator (uPA) pathway has been identified as an assistive mechanism within 
the metastatic cascade of cancer114. It aids in the degradation of surrounding ECM constructs allowing for 
enhanced cell migration and invasion. The Plasminogen Activator Urokinase (PLAU) gene codes for the 
uPA enzyme which activates plasminogen via conversion to plasmin 114. Association between shear stress 
stimulus and the uPA system modulation has been shown for proximal tubular cells 115,  endothelial cells 
116–118, and smooth muscle cells 119; although PLAU upregulation has been linked to metastatic cancers as a 
possible biomarker 120–122, it has yet to be directly tied to mechano-stimulus in cancer.  
Several studies have investigated the effects of shear stress on various cancer types. Previously reported 
responses of cancer cells exposed to shear stress include increased chemoresistance, stem cell markers, 
viability, and changes in adhesion capability 37,107,123. Within breast cancer specifically, shear stress has 
been shown to modulate stemness 124, survival 125, metastasis 125, adhesion 104,123, pH regulation 126, and 
motility 127 though the majority of these studies fail to account for the native 3D microenvironment which 
significantly impacts cellular responses 94,128. To more accurately probe the effects of shear stress on breast 
cancer, in vitro 3D models with shear stress stimulation are needed.  
Here we developed a bioreactor that stimulates breast cancer cells embedded in a 3D hydrogel matrix to 
pulsatile fluid flow allowing for tunable shear stress stimulation 129. We utilized this 3D bioreactor to 
investigate the effects of shear stress on MDA-MB-231, MDA-MB-468, and MCF7 breast adenocarcinoma 
cells in a 3D pleural effusion TME. Through this 3D bioreactor, we identified consistent trends in shape 




exposed to shear stress. These findings suggest that breast cancer cells utilize the PLAU pathway for 
mechanotransduction of shear stress stimulus. The bioreactor is easily modifiable for a range of shear 
stresses, as well as, a variety of cancer cell types, making it a feasible platform for further investigation of 
shear stress in a variety of cancers. 
2.2  Materials and Methods 
2.2.1  Materials and Suppliers 
2.1.1. Cell Culture, Hydrogel Polymerization, Drugs, Inhibitors, and Assays 
The following reagents required for cell culture were purchased from Gibco (Cleveland, TN): DMEM 
growth medium (31-053-028), RPMI growth medium (11875119), antibiotic/antimycotic (15240062), 
0.25% trypsin-EDTA (25-200-056), and L-Glutamine (25030081). Human breast adenocarcinoma MCF7 
cell line (HTB-22), human breast adenocarcinoma MDA-MB-231 (HTB-26) and human breast 
adenocarcinoma MDA-MB-468 cell line (HTB-132), were purchased from American Type Culture 
Collection (ATCC, Manassas, VA). Agarose was obtained from Boston Bioproducts Inc. (P73050G, 
Ashland, MA). Paclitaxel (T7402) was purchased from Sigma-Aldrich (St. Louis, MO). Fetal bovine serum 
(FBS) was purchased from Atlanta Biologicals (Flowery Branch, GA) and type I rat collagen (3443-100-
01) was purchased from R&D Systems (Minneapolis, MN). 
Immunohistochemistry 
The following reagents needed for immunocytochemistry were purchased from Invitrogen (Carlsbad, CA): 
formalin, Goat serum, Triton-X, bovine serum albumin (BSA), phosphate buffered saline (PBS), ProLong 
Gold Antifade Mountant. The anti-Ki-67 antibody (PA5-16785), anti-Caspase-3 antibody (700182), and 
citrate buffer was purchased from Thermo Fisher Scientific (BDB558615, Pittsburgh, PA). Vectastain elite 





3D Shear Bioreactor Components 
The following materials and equipment were purchased for 3D shear bioreactor fabrication: 
polydimethylsiloxane (PDMS) elastomer and curing agent (Sylgard 184, Dow Corning, Midland, MI), 
polyethylene plugs (PEP) (PE16030, SPC Technologies Ltd., Norfolk, UK), poly(methyl methacrylate) 
(PMMA) (11510102, Astra Products, NY, USA), tubing (PharMed BPT, Saint Gobain, Akron, OH), and 
peristaltic pump (FH100, Fisher Scientific, Pittsburgh, PA). The main bioreactor body was constructed 
from a 14 x 14 x 2 cm acrylic block purchased and machined in the machine shop at the University of 
Michigan Physics department. The end plates were constructed from 6 x 6 x ½ inch aluminum plates and 
machined in house.  
2.2.2  Cell Culture 
Cells were cultured in 15 cm tissue culture treated polystyrene plates using RPMI 1640 growth medium 
(MCF7 and MDA-MB-231) or DMEM growth medium (MDA-MB-468) supplemented with 10% FBS and 
1X antibiotic/antimycotic until 80% confluency was reached. Cells were maintained routinely in tissue 
culture, until they were ready to be harvested for use in the 3D bioreactor or 3D control gels.  
2.2.3  Construction and Characterization of Hydrogels 
The interpenetrating network (IPN) hydrogel comprised of two components: agarose (3% w/v), and type I 
rat collagen (500 µg ml-1, Fisher). Hydrogels were supplemented with 10% FBS. Cells were seeded within 
the liquid collagen/agarose solution at a density of 10 million/mL, before transfer to the bioreactor or control 
plate. 
Methods for hydrogel characterization included, scanning electron microscopy (SEM, Philips XL 30, 
SEMTech Solutions, MA), oscillatory rheometry (ARES, TA Instruments, New Castle, DE), and mercury 




SEM characterization was performed for structural analysis of the network. Gels were first flash frozen 
using liquid nitrogen then lyophilized (FreeZone 4.5 plus, Labconco, Kansas City, MO) for at least 24 hours 
before imaging with SEM. 
Oscillatory rheometry was used to investigate shear moduli of the IPN hydrogel. Tests were performed 
using 25 mm parallel plate geometry. Frequency sweeps were performed at 0.5% strain with a frequency 
ranging from 100 rad s-1 to 0.1 rad s-1. The strain value for these tests was determined from strain sweeps 
performed at 0.3 Hz. The complex shear moduli, G*, was calculated from the resulting storage modulus, 
G’, and loss modulus, G”.  
Mercury porosimetry (MicroActive AutoPore V9600 Version 1.02) was utilized for pore structure and 
permeability analysis of the IPN hydrogel. Both 3 and 5 cubic centimeter stem volumes were utilized at a 
mercury temperature of 18.93 °C. 
2.2.4  3D Shear Bioreactor 
Description 
The 3D shear bioreactor was composed of a cell culture medium reservoir made from a modified IV bag 
that was fed through a peristaltic pump leading to the inlet of the bioreactor. The outlet of the bioreactor 
was connected back to the medium reservoir creating a continuous loop within the system. The layout of 
the 3D shear bioreactor flow circuit is depicted in Figure 4A. The bioreactor was machined from an acrylic 
block and consisted of 8 hydrogel stacks positioned radially from an inlet flow chamber. The flow chambers 
were sealed with PDMS gaskets and held in place by two compressed aluminum plates. Images of the 
disassembled and assembled 3D bioreactor are shown in Figure 4B. Continuous and pulsatile cell culture 
medium flow was provided by a peristaltic pump at volumetric flow rate of 2.28 ± 0.035 mL s-1. Cell culture 
medium was pumped through the inlet flow chamber, 8 hydrogel stacks, then back out the collective exit. 
The hydrogel stacks were composed of 3D cell laden agarose-collagen IPN gels (2 mm tall, 11.61 mm 
diameter) in a cylindrical column bordered by 3 mm thick polyethylene plugs (PEP), 0.2 mm thick 




plugs all with a diameter of 12 mm. The smaller diameter gel allowed for a protective notch in the wall of 
the bioreactor, eliminating gel compression during plug insertion. The stack is depicted in Figure 4C. Shear 
stresses were modeled using COMSOL Multiphysics 5.3. A detailed description of the computational model 
is provided in 2.4.3.  
Preparation, Assembly, and Use 
Before use the bioreactor was washed and sterilized with a 24 hour ethylene oxide treatment at 54.4 °C. All 
other components were sterilized by autoclaving, exposure to 70% ethanol, and 30 minute UV treatment. 
The first half of the stack (PEP, PMMA FDN, PEP) was put in place, followed by the cell laden hydrogel. 
The cells were concentrated and spun down to 10 million cells before suspension into the hydrogel. The 
cells and IPN hydrogel solution was polymerized within the bioreactor and conformed to the shape of the 
chamber (3 min, 25 °C). After polymerization, the remaining portions of the stack (PEP, PMMA-FDN, 
PEP) were inserted on top of the hydrogel (Figure 4C). This was followed by placing 5 mm stainless steel 
rods within the flow chambers to control the velocity profile. PDMS gaskets (7 mm thick) were used to seal 
the bioreactor flow chambers and were compressed using bolted aluminum end plates. The inlet and outlet 
flow chambers were then attached to tubing, connecting the cell culture medium reservoir and pump to the 
bioreactor (Figure 4A). The bioreactor and cell culture medium reservoir were placed into the incubator (37 
°C, 5% CO2) and the pump was started at a flow rate of 1.11 cm3 s-1 before gradually increasing to 2.276 
cm3 s-1. Fluid flow was provided in a direction running vertically from the bottom to the top of each hydrogel 
stack.  
Experiments were performed for 72 hours of continuous applied shear stress. Unstimulated control 3D gels, 
encapsulating cells were constructed to mimic the stimulated environment as completely as possible to 
ensure observed phenotypic changes were only attributed to shear stress stimulation within the bioreactor. 
The control gels were housed in 15 cm plates, submerged in 20 mL of cell culture medium and kept within 
equivalent incubation conditions for 72 hours (37 °C, 5% CO2). For drug experiments paclitaxel was 




determined as an effective IC50 in 3D cell culture 130,131. Each experimental condition was repeated a 
minimum of 3 times with up to 8 technical replicates.  
 
Figure 4: Schematic of the 3D shear stress bioreactor. 
A) Layout of the shear bioreactor. Cell culture medium is contained in IV bag, pumped via peristaltic 
pump into the bottom of the reactor, and recirculated into the cell culture medium reservoir, as 
indicated by the directional arrows in the schematic.  
B) Photo of the disassembled (I.) and assembled (II.) bioreactor. I.) Flow plate showing radial flow 
chambers connecting the inlet of media flow to the cell-laden hydrogel stacks. II.) Constructed 
bioreactor, composed of flow plate with PDMS seals and steal endplates bolted together. 
C) Schematic of interpenetrating (IPN) hydrogel stack composition and dimensions. Each stack was 
connected via a radial flow channel to both the inlet and outlet chamber. Hydrogel stack consisted 
of PE plug, PMMA fluid distribution net, PE plug sandwich surrounding cell laden hydrogel to 
both hold the hydrogel in place and evenly distribute fluid flow.  
 
Computational Analysis of Shear Stress 
A numerical model was constructed of the 3D shear bioreactor using COMSOL Multiphysics 5.3 to 
estimated forces experienced within the hydrogel. Symmetry was used to simplify model design. The 
cellular medium flow throughout the flow chambers and hydrogel stack was modeled utilizing Free and 
Porous Media Flow physics, as found in COMSOL and displayed in Equation 1- 4.  




ρ∇ ∙ u3 = 0  (2) 
0 =  ∇ ∙ [−p2I +
μ
ϵp
(∇u3 + (∇u3)T) −
2μ
3ϵp
(∇ ∙ u3)I] − (
μ
ĸbr
+ βF|u3| + Qbr) u3 + F  (3) 
ρ∇ ∙ u3 = Qbr  (4) 
A second, sequential COMSOL model estimated the peak shear stresses experienced by a given cell within 
the hydrogel via laminar flow physics. The governing equations are shown below in Equation 5 and 6.  
ρ(u ∙ ∇)u =  ∇ ∙ [−pI + μ(∇u + (∇u)Τ)] + F      (5) 
ρ∇ ∙ u = 0                         (6) 
Equation 1 and 2 describe the Navier-Stokes equations for free-flowing medium and Equation 3 and 4 
describe the Brinkman equation for porous media flow. Equation 5 and 6 describe the Navier-Stokes 
equation for freely moving fluid. The equation terms are defined as: ρ density, u velocity field, p pressure, 
I identity matrix, μ dynamic viscosity, T temperature, F external forces (e.g. gravity), ϵp porosity, ĸbr 
permeability, βF Forchheimer drag, and Qbr volumetric flow rate.  
Values for the respective material properties were determined experimentally and included under Porous 
Matrix Properties. A hydrostatic water column was used to determine porosity values of PE and PMMA 
materials using Darcy’s law of permeability 132. Porosity was calculated from SEM images of the PE and 
hydrogel and light microscope images of the PMMA FDN on ImageJ. For accurate estimation of these 
values, measurements were repeated 6 or more times each for permeability and a minimum of 3 images 
were quantified for porosity estimations. Permeability of the hydrogel was estimated via mercury 
porosimeter studies. Material characteristic values are listed in Figure 5C.  
Boundary layers were placed along all edges of the models to capture accurate fluid interfaces within the 
3D bioreactor. A mesh analysis was performed to confirm results were independent of mesh size 
(Supplemental Figure 1). Model results are depicted in Figure 6. The primary model (Figure 6A-D) 




the secondary model, simulating fluid flow around an idealized cell (Figure 6E). The resultant viscous shear 
stress was then recorded along the perimeter of the cell, where a maximum incident shear stress value was 
determined (Figure 6F) 37.  
Additionally, hypoxic conditions within the gels were investigated within a COMSOL model. Neither the 
3D control nor the 3D shear stress IPN hydrogels demonstrated hypoxic conditions (Supplemental Figure 
2). Further details on the hypoxic COMSOL modeling conditions can be found in the supplementary 
section.  
2.2.5  Cell Morphometry Analysis 
Slides were stained for Hematoxylin and Eosin (H&E) and imaged under a light microscope at 40X 
magnification for morphometry and shape factor analysis. These images were analyzed using ImageJ to 
quantify cellular area and circularity. A minimum of 3 biological replicates were analyzed each containing 
8 technical replicates. A minimum of 160 cells were quantified for each condition.  
2.2.6  Immunohistochemistry Analysis 
Cell laden hydrogels, once removed from the 3D shear bioreactor or control conditions were placed in 4% 
neutral buffered formalin, paraffin embedded, and sectioned (perpendicular to flow direction) in preparation 
for immunohistochemistry analysis. Briefly, slides were deparaffinized and boiled in citrate buffer for 20 
minutes. Bloxall was used to quench endogenous peroxidase activity for 10 minutes prior to application of 
blocking serum for 20 minutes. Primary antibody solution was incubated for 30 minutes followed by 
washing and secondary antibody incubation for 30 minutes. After washing ABC reagent was applied (30 
min), slides were washed, and DAB was applied for approximately 1 minute while slides were viewed 
under a digital inverted EVOS microscope to ensure adequate color contrast. Slides were then rinsed and 
counterstained with hematoxylin. Images were taken on an inverted Nikon E800 microscope and 
quantification of the resulting images were performed in ImageJ (ImageJ win64). Positive Ki67 or caspase 




normalized to non-drug treated controls for the respective cell line. A minimum of 5 images were taken per 
sample with a minimum of 3 experimental replicates analyzed per condition. Drug treated experimental 
results were normalized to control averages. 
2.2.7  Upregulation of Gene Expression in Cells under Shear Stress 
Total RNA was extracted from gels using a RNeasy Mini Kit (Qiagen, Valencia, CA). An additional buffer 
RPE wash step was amended to the manufacturer’s protocol for enhanced purity. RNA quality and 
quantification were assessed using a NanoDrop 1000 spectrophotometer (NanoDrop, Wilmington, DE). All 
samples used for qPCR analysis passed RNA purity (260/280 and 260/230) with a ratio of 2.0 or better. 
Gene expression analysis was performed in 96 well plates using qRT-PCR on a 7900HT system. 96 well 
plates also included qPCR controls, a reverse transcription control, and a human genomic DNA 
contamination control. Fold change in gene expression between control and shear stress stimulated cells 
was determined using the 2-ΔΔCT method 133. Gene expression analysis was performed on three replicates 
within each cell type. Primer pairs utilized for qPCR PLAU expression were as follows: forward 5’-
GGGAATGGTCACTTTTACCGAG-3’, reverse 5’-GGGCATGGTACGTTTGCTG-3’.   
2.2.8  Urokinase Activity Assay and Zymography 
To quantify the level of urokinase-type plasminogen activator (urokinase, uPA) produced in the shear 
stressed experiments, a Chemicon uPA activity assay kit was performed on collected phenol free DMEM 
medium. All results were well within the sensitivity range of the uPA activity assay kit (0.05 to 50 units of 
uPA activity). In brief, the medium was collected from both shear stress and control gel experiments, passed 
through a 0.22 µm PES sterilized filter, aliquoted, and stored in a -80 °C freezer. 160 µL of sample were 
then added to a 96 well plate and incubated for 2 hours in combination with a pNA grouped tripeptide 
chromogenic substrate (determination of incubation period can be seen in Supplemental Figure 3). Results 




Urokinase activity was additionally evaluated through zymography. Experimental media was concentrated 
66.7-fold through 30 kDa centricon tubes (EMD Millipore, UFC703008) and was run at 100 V at room 
temperature. Zymography resolving gels were fabricated from DI water (9.575 mL), acrylamide (N,N'-
Methylenebisacrylamide, 29:1) solution (5.025 mL), Tris buffer (1.5 M, pH 8.8, 5 mL), 8% milk solution 
(1.74 mL), and plasminogen (118.4 µg) combined with SDS (10% w/v, 200 µL), ammonium persulfate 
(10%, 200 µL), and TEMED (8 µL). Gels were then rinsed three times in triton-100 rinsing buffer (2.5% 
Triton X-100, 50 mM Tris-HCL pH 7.5, 0.05% NaN3) for 10 minutes each. They were then incubated 
overnight in renaturing buffer (0.1 M Glycine pH 8.0 adjusted with NaOH). Gels were rinsed in water three 
times for 5-minute intervals, dyed with Simply Blue safestain for 1 hour, and rinsed in water again. 
Destaining was then performed with methanol (30%), acetic acid (10%) and H2O until band contrast was 
acceptable. Gel imaging was performed on the ChemiDoc™ Touch (BioRad, 732BR0111).  
2.2.9  Statistical Analysis 
All statistical analysis and graphical plots were derived in GraphPad Prism 6.0 (www.graphpad.com, San 
Diego, CA). All morphological data was calculated on ImageJ, and expressed as mean  SEM. All reported 
data is mean  SEM, derived from a minimum of 3 independent biological replicated experiments. 
Statistical comparison was performed using one-way ANOVA for all data except the urokinase activity 
assay and zymography analysis where a two-tailed t-test with Welch’s correction was used.  
2.3  Results 
2.3.1  Hydrogel Characterization and Finite Element Model 
To ensure physiological representation of the pleural effusion TME, investigation of the hydrogel and 
bioreactor shear stress was performed. The biophysical characteristics of the collagen-agarose IPN 
hydrogel, showcasing fiber morphology, shear modulus, and porosity are illustrated in Figure 5. The 




viscoelastic modulus of the IPN hydrogel was determined to be 10.36 ± 0.08 kPa (Figure 5B) and was used 
in conjunction with Equation 7 to determine Young’s modulus. 
E = 2G(1 + v) (7) 
Where E is Young’s modulus, G is viscoelastic modulus, and v is Poisson’s ratio. Poisson’s ratio was 
estimated at 0.5, which is common for polymers such as equilibrium hydrated agarose hydrogels 134. 
Modeling parameters utilized for COMSOL Multiphysics modeling were as follows (porosity, 
permeability): PE plug (60.3 ± 0.8, 9.26 × 10-12 m2); PMMA fluid distribution net (81.8 ± 1.9, 2.33 × 10-11 
m2); IPN hydrogel (77.6 ± 1.8, 7.35 × 10-12 m2) (Figure 5C). These values were then input into a finite 





Figure 5: Material characterization of interpenetrating (IPN) hydrogel stack components. 
A) SEM images of collagen/agarose IPN hydrogels in order of increasing magnification, where a 
reticulated network of collagen fibers was observed within a global agarose construct.  
B) Graphical representation of a frequency sweep from rheometric testing of collagen/agarose IPN 
hydrogels. Four trials were utilized to determine viscoelastic modulus of the IPN hydrogel, 
averaging 10358  81.56 Pa.  
C) Table of material properties for each component of the hydrogel stack. Values were determined by 
experimental measure through SEM analysis, ImageJ quantification, hydrostatic water column flow 
rate, and mercury porosimetry.  
 
Flow velocity within the simulated 3D hydrogel was output by the primary COMSOL model. Fluid flow 
velocity distribution at the center of the hydrogel is depicted in Figure 6D. The velocity of the cell culture 




flow velocity within the y direction was uniform (Supplemental Figure 1C). Fluid velocity within the 
entirety of the hydrogel was averaged and estimated as 3.83 mm s-1. This value was then used as the input 
velocity of the secondary model to estimate the shear stress experienced by cells embedded within the 
hydrogel. An average cell size of 8 µm in diameter, as measured from the H&E stains, and spherical initial 
shape of the cell was assumed. From the model, the resulting maximum shear stress experienced by the cell 
surface was observed to be 5.41 dynes cm-2.  
 
Figure 6: Finite element analysis of the 3D shear bioreactor quantifies shear stress. 
A) Open face bioreactor with dotted line denoting modeled section  




C) Flow velocity of modeled section in m s-1. Velocity ranges from 0-0.3 m s-1 along surface of y-z 
plane.  
D) Flow velocity in x-z plane of midline cross section of hydrogel in mm s-1 
E) Secondary model of shear stress field experienced by a single cell within the IPN hydrogel. Average 
fluid velocity within the hydrogel, determined from primary model (3C) was applied over an 
idealized spherical cell and resulting shear stress on the surface was determined.  
F) Resulting shear stress around perimeter of cell within the flow field demonstrated in Figure 6E. 
Shear stress experienced by the cell is reported as the maximum value of 5.41 dyne cm-2. 
 
2.3.2  Shear Stimulation Significantly Alters Cellular Morphology of Breast Cancer Cells 
Metastatic potential and invasive capability of cancer cells is often indicated through cellular morphology; 
thus shape factor analysis was performed. Cellular morphology of the shear stimulated cells were compared 
to 3D cultured controls. All cell types experiencing shear stress exhibited morphological changes including 
an increase in area and an elongated morphology (Figure 7A). These changes were quantified through 
ImageJ analysis and resulted in a significant increase in cellular area (MDA-MB-231: 1.2 fold, MDA-MB-
468: 1.4 fold, MCF7: 1.8 fold) and a significant decrease in roundness (MDA-MB-231: 0.84 fold, MDA-
MB-468: 0.90 fold, MCF7: 0.71 fold; Figure 7B and C). Perimeter and aspect ratio values were also 
determined to be significantly increased in all shear stressed breast cancer cells, whereas a significant 





Figure 7: Shear stress increases area and decreases roundness in breast cancer cells. 
A) Representative H&E images of shear and control studies for each cell type. Noticeable cellular 
elongation and increased cellular area are seen in all shear samples. All scale bars are 50 µm.  
B) Graph of cellular area quantification comparing control and sheared cells. Shear stress exposure 
shows significant increase in cellular area for all cell types (One-way ANOVA ****p< 0.0001, n≥3 
experiments). 
C) Quantification of cell roundness comparing control and sheared cells. Shear stress exposure shows 
significant decrease in cell roundness for all cell types (One-way ANOVA ****p< 0.0001, n≥225). 
 
2.3.3  Breast Cancer Cellular Proliferation Increases with Shear Stress 
To quantify the effect of shear stress on the proliferation of breast cancer cells, sections of the IPN hydrogel 
were IHC stained for Ki67 expression (hematoxylin counterstained) and quantified (Figure 8). Figure 8A 
shows representative images of control and shear stressed cells expressing Ki67. These results are 
graphically depicted in Figure 8B showing the fraction of proliferating cells more than doubling under shear 





Figure 8: Shear stress increases breast cancer proliferation. 
A) Representative images of Ki67 IHC counterstained with hematoxylin. Deep brown coloring 
indicates a proliferating cell and was quantified manually. Counts were normalized to total cell 
count within each image. Scale bars are 200 µm in the main images and 20 µm in the corner frames 
for MCF7 cells.  
B) Graphical representation of the fraction of proliferating cells for each cell type under control and 
shear conditions (****p< 0.0001, n≥3 experiments). All cell types show significantly increased 





2.3.4  Breast Cancer Cells Show Chemoresistance while under Shear Stress Stimulus 
Given that mechanotransduction can modulate cellular responses to anti-neoplastic agents 37,135,136, breast 
cancer cells were treated with 25 µM paclitaxel for 72 hours. Chemotherapy treatment was administered at 
the previously determined IC50 concentration of 25 µM 130,131. This concentration was sufficient to 
significantly increase cell death for all drug treated controls when compared to non-drug treated controls 
(MDA-MB-231: 3.8 fold, MDA-MB-468: 1.5 fold, MCF7: 2.2 fold; Supplemental Figure 5) as determined 
through IHC caspase 3 quantification. Under paclitaxel treatment, shear stressed cells remained more viable 
than their drug treated control counterparts demonstrated as a significant reduction in cell death (Figure 9A 
and B).  
Additionally, proliferation analysis via Ki67 staining was performed on chemoresistance investigations. 
Proliferation remained significantly increased in drug treated shear experiments when compared to drug 
treated controls. Paclitaxel treatment seemed to have little effect on proliferation values as drug treated 
shear experiments were significantly more proliferative than non-drug treated controls (Supplemental 





Figure 9: Shear stress induced chemoresistance to paclitaxel treatment. 
A) Representative images of caspase 3 IHC staining for MDA-MB-231 cells. Arrows indicate 
examples of cells positively expressing caspase 3.  
B) Cells were treated with paclitaxel chemotherapy (25 M) in either control or shear conditions and 
cellular death was quantified using caspase 3 IHC staining, counterstained with hematoxylin. 
Results were manually quantified and compared to total cell number within the image. The fraction 
of proliferating cells was then normalized to the non-stimulated control average of the respective 
cell type. All cell types showed significantly decreased death under sheared conditions (*p< 0.1, 
n≥3 experiments). Three or more images were quantified for each experiment and a minimum of 
three biological replicates were performed for each condition. 
C) Representative images of Ki67 IHC staining for MDA-MB-468 cells. Arrows indicate examples of 
cells positively expressing Ki67.  
D) Cellular proliferation was analyzed using Ki67 IHC staining on paclitaxel treated experiments. 
Results were manually quantified, and each cell type showed significantly enhanced proliferation 
in sheared samples (**p< 0.01, n≥3 experiments).  
 
2.3.5  Shear Stimulation Significantly Upregulates PLAU Gene Expression 
Changes in gene regulation due to shear stress stimulation was investigated for identification of potential 
mechanotransduction pathways. Change in the gene expression of breast cancer cells, after stimulation with 
shear stress for 72 hours, was quantified using qRTPCR. The PLAU gene was found to have a greater than 
2-fold increase in RNA expression under shear stimulation when compared to controls for both MDA-MB-
231 and MDA-MB-468 cell types. MDA-MB-231 cells increased PLAU expression 3.33 ± 0.89-fold, 




(Figure 10A).  All experimental runs are normalized to their respective controls, as such all control 
conditions result in a fold upregulation of 1. 
2.3.6  Protein Expression Confirms Enzymatic Activity of Urokinase 
The PLAU gene encodes for the enzymatic protein urokinase which functions to degrade plasminogen into 
plasmin. It is a secreted protein present in all cells where it aids in the degradation of surrounding 
extracellular matrix to assist in cell migration/invasion. To investigate urokinase protein expression, both a 
commercially available enzymatic activity assay and a plasminogen zymography test was performed. 
Experimental medium was collected after the completion of three 72-hour MDA-MB-468 experiments for 
use in protein/enzyme analysis. Shear stressed cells had significantly higher urokinase activity than the 
unstimulated controls (2.5 fold; Figure 10B). As a means for independent verification, zymography was 
performed on plasminogen acrylamide gels. After conclusion of the trial, experimental medium was 
concentrated and run in the zymography gel. The resulting band intensity was normalized to its respective 
control. Shear stimulated MDA-MB-468 cells significantly increased secretion of uPA (1.4 fold) (Figure 





Figure 10: Activity assay and zymography confirm enhanced urokinase activity under shear stimulation. 
A) qPCR analysis on PLAU expression showed significant upregulation for MDA-MB-231 (*p< 0.1, 
n≥3 experiments) and MDA-MB-468 (**p< 0.01, n≥3 experiments). MCF7 cells showed an 
increase in PLAU expression but was not significant (n≥3 experiments).  
B) Confirmation of PLAU upregulation was performed using a urokinase activity assay on MDA-MB-
468 experimental medium. Results showed a significant increase in enzymatic activity for shear 
samples normalized to controls. 
C) Additional confirmation of urokinase protein activity was performed via plasminogen zymography. 
Band intensity for three MDA-MB-468 experimental sets is shown (32 kDa low molecular weight 
form uPA).  
D) Quantification of the zymography band intensity was normalized to their respective controls and 
statistically analyzed with a two tailed t-test. MDA-MB-468 sheared samples showed a significant 
increase in band brightness, indicating increased urokinase enzyme activity.  
 
2.4  Discussion 
Both cancer and non-malignant cells experience shear stress in many microenvironments 42,100,106. The 




interstitial flow, thus increasing the shear stress experienced by cancer cells 100,108,112. This mechanical 
stimulus aids in cellular invasion while hindering chemotherapy delivery to the center of the tumor, 
resulting in chemoresistance and a flow gradient outwards from the tumor 37,137–139. These findings 
emphasize the importance of mechanotransduction by shear stress within the TME.  
A variety of methods to apply and study the effects of shear stress on cells have already been devised. 
However, many of these methods study the application of force on a monolayer culture 99,102,123,140. Though 
2D systems can apply uniform stimulation, these methods lack the physiologic 3D shear stress found within 
the TME. The 3D shear models currently in existence incorporate microfluidic design or single cell analysis, 
which replicate the in vivo shear stress experienced by CTCs 37,107. The constructs that investigate interstitial 
shear stress effects often only investigate migratory behaviors 141 through microfluidics 110 and the use of 
Boyden chambers 142. While this type of device is advantageous for observation of small number of cells, 
it provides a hurdle for further downstream analysis such as western blot or qRT-PCR. In this Chapter, we 
advance the existing shear bioreactor designs 129 by: 1) incorporating a 3D IPN hydrogel that matches the 
morphology and modulus of the pleural effusion TME ECM, 2) embedding breast cancer cells within a 3D 
IPN hydrogel and providing variable pulsatile flow to the cells, 3) constructing a numerical model for a 
more accurate portrayal of fluid flow and shear stresses experienced by the breast cancer cells within the 
3D bioreactor, and 4) increased yield of cells for molecular biology assays after experimental completion 
(not typical with microfluidic devices).  
The agarose IPN hydrogel was chosen to provide a 3D microenvironment capable of easy stiffness 
modulation, encapsulation of cells, and blank background free of excess growth factor stimulation as to 
avoid excess signaling cues to the cells 143,144. The collagen type I component was included to provide 
minimal and easily controlled adhesive signal for the cells within the network  to sense the shear stress 
stimulation and due to its key role within the breast cancer ECM 143,144. This hydrogel design has been 
previously utilized and investigated 143–146. With this combination IPN gel, cells could be encapsulated in 




tissue has been reported to have a Young’s modulus of approximately 3.25 kPa whereas breast tumors range 
from 6.41 – 42.52 kPa in stiffness depending on disease progression 147,148. The stiffness of the IPN agarose-
collagen hydrogel fell well within this range attaining a Young’s modulus value of 31.08 kPa. At this 
stiffness the IPN hydrogels most closely replicated intermediate to high grade infiltrating ductal carcinoma 
148 and could be easily adjusted to suit alternate TME biophysical properties. 
We developed a two-step COMSOL model that enables greater accuracy when calculating estimated shear 
force experienced by cells captured within the 3D microenvironment. The first model uses a 3D rendering 
of the shear bioreactor to determine the fluid velocity and velocity distribution within the hydrogel. 
Subsequently, the estimated velocity is input as the inlet velocity for the secondary COMSOL model that 
applies the input flow over an ideal spherical cell. Due to the complicated IPN network, specific adhesive 
sites for the cell are not included, rather the shear velocity along the surface is calculated and the maximum 
shear stress is reported. This two-step system is more comprehensive than previous models for similar 
bioreactors 129 due to the inclusion of the entire continuous flow path within the bioreactor, as well as, all 
components of the hydrogel stack, which were found to be relevant in model results.  While majority of 
cells experience the same maximum shear value regardless of their vertical positioning within the hydrogel, 
there is some variation in flow velocity in the X-Z plane. This is due to the location of the inlet flow chamber 
lateral to the hydrogel stack and respective flow distribution components. From these models, advanced 
estimates of cellular stimulation can be predicted with spatial accuracy within the hydrogel. Average shear 
stress values experienced by cells was determined to be 5.41 dynes cm-2.  
 When exposed to shear stimulation in  2D, epithelial ovarian cancer cells have been shown to elongate and 
increase formation of stress fibers 102, whereas endothelial cells align in the direction of the shear force and 
elongate 102,140. The cell morphological data from our breast cancer cell lines under shear stress is consistent 
with these outcomes. Similarly, several studies demonstrate alterations in gene expression related to 




increases the proliferative ability of the breast cancer cells, where as normal vascular endothelial cells have 
been found to inhibit proliferation in the presence of shear stress 150.  
Gene expression analysis showed a significant enhancement of PLAU under shear stimulation. This enzyme 
primarily activates plasminogen (pro enzyme) to plasmin (multiple substrate cleaving enzyme) 151. Plasmin 
then aids in the migratory cascade through degradation of ECM components, activation of MMPs, release 
of growth factors, and functions as a feed forward mechanism on the uPA-uPAR complex by activating 
pro-uPA to active uPA 152,153. Recently, uPA and its interactome have become a point of interest in cancer 
research due to its role in metastasis, proliferation, angiogenesis, its frequent aberrant expression within a 
variety of cancers, and its potential role as a diagnostic biomarker and therapeutic target 114,153. Many 
alternative studies have tied the uPA system with cancer progression such as Huang and colleagues who 
found a significant decrease in tumor metastasis with uPA knockdown in MDA-MB-231 cells 154. 
Additionally, shear stress has been identified as a driver of PLAU expression 115,117,118. However, to our 
knowledge this is the first time the PLAU excess has been tied directly to shear stress stimulus in cancer. 
The enhancement of uPA expression found under shear stress stimulation suggests support of the metastatic 
cascade via mechanotransduction mechanisms. This result is further supported by the enhanced uPA 
enzyme activity produced by the shear stress stimulated cells and morphological changes indicating 
enhanced invasive potential, emphasizing the importance of mechanotransduction to the metastatic cascade.    
Finally, we investigated whether breast cancer cells under shear stress show a greater resistance to 
chemotherapy. Cells stimulated with shear stress were more resistant to paclitaxel treatment compared to 
unstimulated controls emphasizing the necessity to consider shear stress stimulus in treatment 
investigations. These findings are consistent with Ip et al. who tested paclitaxel treatment of ovarian cancer 
spheroids under shear stress 37 finding enhanced drug resistance. When cellular proliferation was 
investigated simultaneously with drug treatment, little effect was found on the proliferating population 




importance of recapitulating the in vivo mechanical microenvironments for fundamental and translational 
approaches.  
The design of this shear bioreactor enables simultaneous 3D cell culture along with tunable shear stress that 
provides a physiologic mechanical microenvironment for cancer biology investigations. Under these 
conditions more accurate results for in vitro modeling, drug screening, and therapeutic investigation for 
breast cancer can be realized. The versatility of this model provides a platform that can be applied to a 
multitude of cancer cell types and drug screening, enabling a better understanding of disease states and their 
responses.    
2.5.  Conclusion 
In conclusion, an improved 3D bioreactor capable of applying tunable shear stress to breast cancer cells 
within an IPN hydrogel matrix was designed and constructed. With the application of shear stress, 
morphological changes were observed in the breast cancer cells, including increased cellular area and 
decreased roundness. Shear stress stimulation also increased cellular proliferation, and enhanced PLAU 
expression. Cells exposed to shear stress demonstrated higher resistance to chemotherapy treatment with 
paclitaxel, and the proliferation in this condition was unaffected. These findings demonstrate that breast 
cancer cells under shear stress stimulus adopt enhanced proliferation, invasion, and chemoresistant 
phenotypes, emphasizing the importance of shear stimulus in a 3D setting. This data reveals the role of 
PLAU in modulating shear stress induced mechanotransduction in breast cancer cells and provide 
researchers with a new 3D platform for understanding the fundamentals of shear stress induced 







CHAPTER 3156: Upregulation of Cox-2 in MCF7 Breast Cancer Cells when Exposed to Shear 
Stress
3.1  Introduction 
Breast cancer remains the number one newly diagnosed and second overall most lethal form of cancer for 
women in the united states1. The etiology and pathology of breast cancer is extremely diverse, with highly 
aggressive invasive breast cancers demonstrating poor clinical prognoses. The molecular mechanisms 
underlying the aggressive nature of certain forms of invasive breast cancer are poorly understood. 
Cyclooxygenase-2 (COX-2) expression is elevated in several neoplasias, and are implicated to be directly 
involved in mammary carcinogenesis157. COX2 expression holds prognostic value, being associated with 
significantly poor survival, enhancing a tumor-promoting microenvironment and enhanced ability to induce 
metastasis158. In fact, COX-2 inhibitors including celecoxib have been documented to play both a 
chemotherapeutic and chemo-preventive role in breast cancer159,160. Furthermore, knockdown of COX2 
gene expression is documented to result in a loss-of-function of metastatic invasion of human breast cancer 
cells, with the key implication being the involvement of the COX-2 pathway in mechanotransduction161.  
In this study, we sought to test the hypothesis that shear stress within the mammary tumor 
microenvironment may regulate COX-2 expression, leading to metastatic traits in luminal breast cancer 
cells. Specific to metastatic breast cancer, an often overlooked aspect of the tumor microenvironment 
(TME) is the application of physiological mechanical stimuli such as compression, shear stress, stiffness, 
and 3D cell culture, all of which continuously influence cellular signaling and downstream effects. Breast 
cancer cells within TME experience a wide range of shear stresses from vascular blood flow, interstitial 




promote cell motility, adhesion, and metastasis in breast cancer, as well as, in a variety of other cancer 
types99–104. These shear stress values are predicted to be within the range of 0.1 dynes/cm2 for interstitial 
flows, 0.5-30 dynes/cm2 within the blood stream100, and up to 18.4 dynes/cm2 within pleural effusions7, 
though in vivo measurements remain elusive and are desperately needed. To more fully understand the 
influence of the physiologic shear stress stimulation on breast cancer progression, bioengineering models 
that consider the physiological 3D TME and mechanical stimuli are required.  
To address this critical need, in this report we utilize our previously developed shear stress bioreactor162 to 
stimulate MCF7 luminal A breast adenocarcinoma cells within a highly tunable 3D microenvironment. 
Consistent with our previous studies, we find that breast cancer cells stimulated for 24 hours alter their 
morphology via an increase in cellular area and a decrease in circularity. Stimulated breast cancer cells also 
enhance their proliferation potential, chemoresistance, and expression levels of a variety of genes tied to 
metastasis, chemoresistance and mechanotransduction. MCF7 cells upregulated expression of COX-2, and 
established its role in mechanotransduction161 via shear stress stimulation. To our knowledge, this is the 
first investigation linking COX-2 upregulation shear stress mechanotransduction.   
3.2  Materials and Methods 
3.2.1 Cell Culture  
Cell culture reagents purchased from Invitrogen (Carlsbad, CA) included: RPMI 1640 growth medium, 
antibiotic/antimycotic, type I collagen, fetal bovine serum (FBS) and 0.25% trypsin-EDTA. Human breast 
adenocarcinoma MCF7 cell line (HTB-22) was purchased from American Type Culture Collection (ATCC, 
Manassas, VA). Agarose was purchased from Boston Bioproducts Inc. (P73050G, Ashland, MA). 
Celecoxib (PHR1683) and paclitaxel (T7402) were purchased from Sigma-Aldrich (St. Louis, MO). 
AlamarBlue reagent was purchased from Fisher Scientific, Pittsburgh, PA). 
MCF7 cells were cultured in 15cm tissue culture treated polystyrene plates using RPMI 1640 growth 




Cells were maintained routinely in tissue culture, until harvested for use in the 3D bioreactor. MCF7 cells 
were concentrated to 1X 106 cells/mL before suspension into the agarose/collagen hydrogel. Hydrogels 
were polymerized as described previously162. Briefly, the interpenetrating network (IPN) hydrogel 
comprised of 3% w/v agarose, and 500µg/ml type I collagen. Hydrogels were supplemented with 10% FBS.  
3.2.2 Immunocytochemistry  
Reagents for immunocytochemistry were purchased from Invitrogen (Carlsbad, CA) and included: 
formalin, Goat serum, Triton-X, bovine serum albumin (BSA), phosphate buffered saline (PBS), 2-(4-
Amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI), Alexafluor488-conjugated phalloidin, 
ProLong Gold Antifade Mountant. Anti-Ki-67 antibody was purchased from Thermo Fisher Scientific 
(BDB558615, Pittsburgh, PA), and COX-2 antibody (sc-376861) was purchased from Santa Cruz 
Biotechnology (Dallas, TX).  
Once hydrogels were removed from static culture or the bioreactor they were placed in 4% neutral buffered 
formalin. They were then processed for paraffin embedding and subsequently sectioned perpendicular to 
fluid flow stimulus. Slides were blocked for one hour (composed of 10% goat serum and permeabilized 
with 0.1% Triton-X) and incubated for two hours with stain specific antibody (DAPI, Alexafluor488-
conjugated phalloidin, anti-Ki-67, or anti-COX-2) diluted with formulated blocking buffer. Slides were 
subsequently washed with 1X PBS and DI H2O. Finally, antifade mounting agent was used to mount cover 
slides.  Resulting slides were imaged with the Olympus IX81 confocal microscope (equipped with 
Yokogawa CSU-X1 confocal scanning laser unit, iXon x3 CCD camera, and Metamorph 7.8 software). 
Quantification of the resulting images was performed in ImageJ (ImageJ win64). Mean RGB values were 
recorded for anti-COX-2 images and normalized to DAPI values for each picture. The number of cells 
expressing Ki67 was normalized to the total number of cells imaged.  A minimum of 5 images was taken 




3.2.3  3D Shear Bioreactor  
Shear bioreactor construction, description, assembly and use was described previously162. Briefly, 
continuous cell culture medium flow was provided from a peristaltic pump at volumetric flow rate of 2.276 
cm3/s. Cell culture medium was pumped through the inlet flow chamber, hydrogel stacks, then back out 
into the growth medium reservoir. The bioreactor and cell culture medium reservoir were placed into the 
incubator and the pump was started with a flow rate of 1.11 cm3/s then gradually increased to 2.276 cm3/s, 
providing fluid flow from the bottom to the top of each hydrogel stack. Experiments were performed for 
either 24 or 72 hours of continuous applied shear stress. For experiments performed using celecoxib, or 
paclitaxel, compounds were dissolved in the perfusate to final concentrations of 10µM and 25µM 
respectively. Celecoxib inhibitor experiments were performed for 24 hours and paclitaxel drug experiments 
were performed for 72 hours. Each experimental condition was repeated a minimum of 3 times with 4 
replicates of each shear condition within each trial. Shear stress was modeled using COMSOL 
Multiphysics4.2a.  
To modulate the shear stress experienced by cells within the 3D bioreactor, stainless steel rods of 5mm or 
30mm length were fitted into the radial flow chambers of the bioreactor in an alternating pattern 
(Supplemental Figure 6A). Placement of these rods modulated the fluid flow velocity within the hydrogels, 
and thus the shear stress experienced by the respective encapsulated cells (Supplemental Figure 6D). 
3.2.4  Cell Morphology 
Hematoxylin and Eosin (H&E) staining was used in conjunction with ImageJ software to quantify shape 
factor changes, including, cellular area and circularity. Images were taken at 40X magnification via an 
inverted color microscope.   
3.2.5  Cell Viability - AlamarBlue fluorescence 
Cell viability of the MCF7 cells within the hydrogels was performed using alamarBlue metabolic activity. 




RPMI cell culture medium for 2 hours. One-tenth dilution of alamarBlue reagent was then added to each 
well and the plate was incubated for an additional 1.5 hours. After this incubation period the cell culture 
medium was removed, placed into a separate 12 well plate and read using Synergy HT microplate reader 
(BioTek Instruments, Inc. Winooski, VT) at 560nm excitation, and 590nm emission. The resulting 
fluorescence values were normalized to unstimulated 3D controls and used to describe % Normalized cell 
viability. 
Drug studies were performed on all experimental and control conditions to investigate the presence of 
chemotherapeutic resistance due to shear stress stimulation. A previously identified IC50 concentration of 
paclitaxel (25µM) was used to investigate drug resistance in cells exposed to shear stress162–164.  
3.2.6  Gene Expression  
Gene expression analysis was performed using a commercially available quantitative PCR array (PAHS-
131Z, human breast cancer array, Qiagen, Valencia, CA). The commercial plate included qPCR controls 
including a reverse transcription control, human genomic DNA contamination control, and a positive PCR 
control. MCF7 cells within the collagen type I/agarose IPN hydrogels were either exposed to 24 hours of 
shear stress in the 3D shear bioreactor or maintained in control unstimulated 3D hydrogels in the incubator. 
Following 24 hours, total RNA was extracted from cells using the RNeasy Mini Kit (Qiagen, Valencia, 
CA) following manufacturer’s protocol. The NanoDrop 1000 spectrophotometer (NanoDrop, Wilmington, 
DE) was used to determine sample concentration and quality and all samples used in the PCR array passed 
RNA purity (260/280 and 260/230) with a ratio of 2.0 or better. The 2-ΔΔCT method133 was used to determine 
fold changes in gene expression between MCF7 cells exposed to shear and control unstimulated cells.  
3.2.7  Computational Analysis of Shear Stress 
Computational analysis of shear stress values was previously described162. Briefly, material property 
constants were determined through direct measurement via hydrostatic water columns, SEM images, and 




shear stresses on an idealized cell (Supplemental Figure 6A). A mesh analysis was conducted to confirm 
accuracy of shear values (Supplemental Figure 6B).  
The COMSOL model of the 3D bioreactor showed shear stress values within the hydrogels to be 3.25 
dyne/cm2 under 5mm rod conditions, and 3.04 dyne/cm2 under 30mm rod conditions (Supplemental Figure 
6C, 1D). The variation in shear stress values was manipulated through variation in rod length within the 
reactor’s radial flow channels. Additional ranges in shear stress stimulation can be reached by altering input 
peristaltic pump settings in future investigations.  
3.2.8  Statistical Analysis  
Statistical analysis and graphical plots were created in GraphPad Prism 5.0 (www.graphpad.com, San 
Diego, CA). All drug treatments were normalized to their respective control untreated conditions, and 
viability was expressed as a percentage. All data is represented as meanSEM and is a result of a minimum 
of 3 independent experiments.  
3.3  Results 
3.3.1  Shear Stress Increases Cellular Area, Decreases Circularity, and Increases Proliferation of 
MCF7 Cells  
Application of shear stress can change cell shape140 and this morphological change can influence cell fate165. 
Therefore, circularity and area of the MCF7 cells under shear stimulation were compared to unstimulated 
controls.  MCF7 cells experiencing shear stress exhibited morphological changes, elongating them and 
making them more ellipsoidal (Figure 11A). The quantification of morphometric changes revealed a 
significant increase in cellular area for all MCF7 cancer cells exposed to shear when compared to controls 
(Figure 11B). Similar results were found when comparing circularity of the breast cancer cells. All shear 
stressed breast cells displayed a decrease in cell circularity with enhanced consequences under longer 




Changes in proliferation of shear stress stimulated MCF7 breast cancer cells were assessed through Ki-67 
expression quantification (Figure 11D). Significantly increased Ki-67 expression was found for both 24 
hours and 72 hours shear stressed conditions, when compared to their respective controls (Figure 11E).  
 
Figure 11: Morphological and proliferation changes in MCF7 cells under shear stress stimulus. 
A. MCF7 cells were dual stained with phalloidin (Green) for actin and DAPI (Blue) for cell nuclei in 
order to qualitatively confirm the morphological changes observed in the H&E study. 
Representative images of MCF7 control cell samples incubated for 24 and 72 hours respectively 
within IPN agarose/collagen hydrogel with no shear applied and MCF7 cells exposed to 24 or 72 
hours of shear stress respectively (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
). Cells in the control condition 
appear rounded with high circularity. Scale bar is 20µm.  
B. Morphometric analysis and quantification of change in cellular area (µm
2
) in cells stained with 
H&E exposed to 24 or 72 hours of shear (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
) as compared to control 
conditions. Shear area for both 24 and 72 hours was significant when compared to no shear controls 
of respective shear exposure time. All values for area were significantly different when comparing 




C. Morphometric analysis and quantification of change in cellular circularity (dimensionless) in cells 
exposed to 24 or 72 hours of shear (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
) as compared to control 
conditions. All values for circularity were significantly different when comparing 24 vs. 72 hour 
shear exposure. (**** p< 0.0001, one-way ANOVA, n≥5).  
D. Changes in proliferation with shear were assessed by staining MCF7 cells with the Ki67 antigen 
(red), nuclei were counterstained with DAPI (blue). Representative images of MCF7 control cell 
samples and cell samples exposed to shear (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
) were incubated for 
24 and 72 hours respectively within IPN agarose/collagen hydrogel. More proliferation was 
observed under both shear conditions lasting 24 or 72 hours when compared to respective controls. 
Scale bar is 20µm.  
E. Quantification and statistical comparison of cells expressing Ki67 in each condition. The fraction 
of cells expressing Ki67 was determined by counting cells positive with Ki67 antigen normalized 
to the total number of cells in that given field of view. Both shear conditions show a significant 
increase in the proportion of cells expressing Ki67, indicating an increased proliferative capacity 
with exposure to shear stress. This increase in Ki67 expression is intensified by prolonged shear 
exposure. (**** p<0.0001, * p<0.01, one-way ANOVA, n≥3 experiments). 
 
3.3.2  Shear Stress Significantly Upregulates Genes Implicated in Chemoresistance, Metastasis, 
Invasive, and Proliferation  
qRT-PCR quantified the changes in the gene expression of luminal A breast cancer MCF7 cells after 
stimulation with shear stress for 24 hours when compared to unstimulated controls. Seven genes were found 
to have a greater than two-fold increase under shear stimulation when compared to control. These genes 
included: PTGS2 (Prostaglandin-endoperoxide synthase 2, COX-2, 3.63-fold increase), SERPINE1 (serpin 
peptidase inhibitor, PAI-1, 3.02-fold increase), PLAU (Plasminogen activator, ATF, 2.80-fold increase), 
HIC1 (hypermethylated in cancer 1, ZBTB29, 2.62-fold increase), BCL2 (B-cell lymphoma 2, 2.57-fold 
increase), TP53 (tumor protein 53, 2.24-fold increase), and ABCG2 (ATP-binding cassette, ABC15, 2.17-
fold increase). The alterations observed in these genes implicated a chemoresistant, metastatic, invasive, 
and proliferative phenotype of MCF7 breast cancer cells under shear stress166–172.          
3.3.3  Celecoxib Treatment Successfully Inhibits COX-2 Overexpression Under Shear stress  
Given that COX-2 was upregulated under shear stress compared to unstimulated control, the protein 
expression of COX-2 was validated by immunofluorescence. MCF7 breast cancer cells exposed to shear 




from shear stimulation was successfully inhibited with celecoxib treatment reducing the expression of 
normalized red fluorescence (Figure 12A, B). No significant change in MCF7 breast cancer cell 
proliferation was observed under the celecoxib treatment subjected to 3.04 dyne/cm2 stimulation, whereas 
significant reduction in proliferation was observed with 3.25 dyne/cm2 stimulation (Figure 12D). These 
results indicate that celecoxib treatment is successful at inhibiting the shear stress-stimulated upregulation 
of COX-2 in MCF7 breast cancer cells. However, celecoxib treatment does not contribute to a reduction in 
MCF7 proliferation, unless stimulated at higher shear stress values.  
 
Figure 12: COX2 expression and ki67 response to paclitaxel treatment in MCF7 shear stress stimulated 
cells. 
A. Cells were dual stained with Cox-2 (red) and DAPI (blue) for cell nuclei. Representative image of 
MCF7 control cell samples incubated for 24 hours within IPN agarose/collagen hydrogel with no 
shear applied, cell samples exposed to 24 hours shear stress (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
), 
and cell samples exposed to 24 hours of shear stress (3.04 dyne/cm
2
 and 3.25 dyne/cm
2
) with 
celecoxib treatment (10µM) by perfusion in media. Scale bar is 20µm.  
B. Quantification of Cox-2 expression in each 24 hour condition. Cox-2 expression is significantly 
increased under both shear conditions as compared to control. (**** p< 0.0001, one-way ANOVA). 
With celecoxib treatment Cox-2 expression is significantly reduced as compared to the respective 
untreated shear condition. (**** p<0.0001, one-way ANOVA).  
C. Representative image of Ki67 and DAPI stains after 72 hours of incubation with paclitaxel (25µM) 
treated in shear conditions (3.04 dyne/cm
2
 and 3.25 dyne/cm
2




paclitaxel treated shear conditions but not as wide spread as control and untreated shear conditions. 
Scale bar is 20µm.  





) for 72 hours, exposed to paclitaxel, and 24 hours, exposed to inhibitor celecoxib, 
respectively. Ki67 expression was significantly reduced under both shear conditions when treated 
with paclitaxel. This demonstrates a reduction in proliferation. (**** p<0.0001, ** p<0.001, one-
way ANOVA). Proliferation is not significantly reduced through Cox-2 inhibition treatment with 
celecoxib under 3.04 dynes/cm
2
 but was when exposed to 3.25 dynes/cm
2
 of shear stress. (* p<0.01, 
one-way ANOVA).  
E. Quantification of cell viability using alamarblue after 72 hours of incubation with paclitaxel 
(25µM). Drug treatment significantly decreased cell viability in all experimental conditions. 
However, cells exposed to shear stress, were more resistant to paclitaxel treatment. (**** p<0.0001, 
* p<0.01, one-way ANOVA).  
 
3.3.4  Shear Stress Stimulated MCF7 Cells are Chemoresistant to Paclitaxel  
Stemming from the observed upregulation of drug resistant genes seen in the PCR array, MCF7 cells were 
treated with 25µM paclitaxel for 72 hours to investigate chemoresistance potential (Figure 12C). 
Quantification of Ki67 expression revealed that shear stressed and paclitaxel treated MCF7 breast cancer 
cells had significantly less proliferation than their non-drug treated counterparts. Paclitaxel caused 
successful MCF7 breast cancer cell death in the unstimulated control at an IC50 concentration of 25µM, and 
viability of 55.73±2.40%. Paclitaxel treatment on shear stress stimulated MCF7 remained significantly 
more viable than the drug treated no shear control (Figure 12E). These findings suggest that MCF7 breast 
cancer cells stimulated with shear stress, are chemoresistant, and can survive more effectively under 
paclitaxel treatment. However, under paclitaxel treatment, proliferation of the shear stimulated MCF7 
breast cancer cells is reduced, supporting the drug’s effectiveness at inhibiting growth rate of the tumor.  
3.4  Discussion 
Interstitial and vascular fluid flow apply shear stress to cells in many microenvironments42,100,106. The 
mammary TME enhances both inflammation and vascularity in the surrounding tissue, providing an abrupt 
increase to interstitial flow and shear stress experienced by the tumor cells100,108,112. The outward moving 
flow gradient results in chemoresistance by impeding drug delivery and promotes cancer cell invasion37,137–




(CTCs), that lead to distant seeding of breast cancers100. Within pleural effusion, one of the most common 
metastatic sites for mammary tumors, cells experience an even larger range of shear stresses stemming from 
breathing and corresponding lung movement7,111. In all these scenarios, breast cancer cells are mechanically 
stimulated in ways that are typically overlooked in most drug screening, drug efficacy and other treatment 
studies. Therefore, we created an in vitro bioengineering model to understand how shear stress affects breast 
cancer cells in a dynamic mechanical microenvironment. 
Post shear stress stimulation, breast cancer cell morphology was observed to significantly change. An 
increase in cellular MCF7 area and decrease in circularity was observed for all shear magnitudes and time 
points compared to controls. As morphological changes have been known to influence cellular fate165 and 
elongation has been shown to indicate invasive potential173, resulting levels of proliferation and cell death 
were investigated. Cancer cell proliferation increased under shear stress stimulation (Figure 11E) and no 
significant change in cell death was observed (Figure 12E). These data indicated that the physiological 
levels of shear stress have a strong influence on progression of breast cancer, through enhanced proliferation 
potential and thus growth of the tumor.  
Although COX-2 is critical for mechanotransduction within breast cancer cells, and is a known effector of 
migration, proliferation, and invasion161, it is not yet known if shear stress mechanotransduction in breast 
cancers is mediated via COX-2. Therefore, we investigated the COX-2 levels in MCF7 cells under shear 
stress. Assessment of mRNA expression post shear stress stimulation revealed significant upregulation of 
COX-2, PAI-1, PLAU, HIC1, BCL2, TP53, and ABCG2 compared to unstimulated controls. The increase 
in COX-2 gene expression translated into increased COX-2 protein expression, similar to observations in 
other cells in response to shear174,175. COX-2 expression is correlated with mechanotransduction in breast 
cancer cell lines161, indicating that an increased COX-2 expression, along with an increase in expression 
levels of PAI-1, may represent a more invasive phenotype in MCF7 cells exposed to shear stress. Indeed, 
Yoon et al. reported increased force generation and metastatic ability, invasion and cytoskeletal remodeling 




inhibition of the mechanotransduction through COX-2 via celecoxib hindered shear stress-induced COX-2 
expression in MCF7 cells (Figure 12B). However, COX-2 inhibition did not result in a change in 
proliferative capacity of cells stimulated with 3.04 dyne/cm2 but did significantly reduce the proliferation 
under the higher shear stress value of 3.25 dyne/cm2 (Figure 12D). It is predicted that the low shear stimulus, 
having not increased proliferation levels as drastically as the 3.25 dyne/cm2 stimulus, could not be reduced 
as severely and thus no significant reduction in proliferation was observed. This reduction in proliferation 
via celecoxib treatment is consistent with previous findings of COX-2 inhibition on 2D monolayers of 
MCF7 cells176. These observations indicate that 3D culture and magnitude of shear stimulation may alter 
MCF7 proliferative response to celecoxib. The inhibition of the COX-2 pathway is highly relevant in breast 
cancer treatment, as it is a component of clinical treatment in combination with other chemotherapy drugs 
and treatment modules177. In future studies, the downstream effects of COX-2 modulation will be 
investigated in order to tie it more directly to specific shear stress mechanotransduction pathways161. 
Due to the increased expression of the drug resistant gene ABCG2 and anti-apoptotic gene BCL-2, we 
investigated whether breast cancer cells under shear stress showed a greater resistance to chemotherapy. 
Resulting cell viability studies after paclitaxel treatment showed a significant increase in viability when 
compared to drug treated controls. Several reports in literature suggest a causal link between COX-2 and 
the development of multidrug resistance via ABCG2 in breast cancer178,179. COX-2 expression is also 
documented to induce genomic instability, BCL-2 expression and chemoresistance in MCF7 cells180, further 
attesting to the potential link between shear stress stimulation mediated COX-2 expression to the 
development of a chemoresistant phenotype. Therefore, shear stress stimulation and associated 
mechanotransduction pathways need to be considered when developing new drug therapies targeting breast 
cancer.  
The use of this experimental model is limited in its down-stream analysis as well as its live cell interrogation 
during shear stress stimulation. The agarose component of the hydrogel is non-digestible by the 




As cells cannot yet be removed from their 3D hydrogel environment, downstream quantification through 
sorting, such as in FACS analysis, is prevented. Deeper interrogation of this mechanotransduction pathway 
both up and downstream of COX-2 would also be beneficial for the development of future pathway targets 
critical to the cellular transmission of shear stress signaling. Additional studies should be performed in 
similar cell lines as well as patient samples for confirmation of physiological application. 
3.5  Conclusion 
Through the use of a highly versatile 3D shear stress bioreactor, our results indicate that MCF7 breast 
adenocarcinoma cells stimulated by shear stress displayed enhanced invasive potential, proliferation, and 
drug resistance to paclitaxel chemotherapy. We determined COX-2 to be a key mediator, bridging the gap 
between mechanotransduction and the development of a malignant phenotype. Targeting COX-2 
overexpression with a clinically available inhibitor, celecoxib, significantly mitigated the development of 
the malignant phenotype upon exposure to shear stress.  Our results suggest that celecoxib or other COX-2 
inhibitors can be a potent neo-adjuvant therapy for breast cancer, to improve sensitivity to 
chemotherapeutics. Lastly, our findings demonstrate that mechanotransduction-oriented pathways play a 
major role in the development of aggressive breast cancer phenotypes and are an important consideration 







Chapter 4: Compressive stimulus enhances ovarian cancer proliferation, invasion, chemoresistance 
and mechanotransduction via CDC42 in a 3D compression bioreactor
4.1  Introduction 
As ovarian cancer grows and develops, it is uniquely subjected to a variety of physiological mechanical 
forces. The primary tumor proliferates, displacing the surrounding extracellular matrix as well as the native 
cells within the ovary creating compressive forces within the growing tumor181. Additionally, patients often 
present with ascites, or the retainment of fluid within the peritoneal cavity. This fluid build-up submerges 
the ovaries in an aberrant environment that further compresses the primary tumor site through hydrostatic 
pressure. As the patient goes through their daily lives, the movement and placement of this fluid changes, 
altering the hydrostatic pressure in a time dependent manner.  This resulting compression stimulates the 
cells and affects downstream signaling, known as mechanotransduction.   
Mechanotransduction has been previously shown to heavily influence the progression and fate of a variety 
of cell types. Compression182, tension183, stiffness184, and shear stress87 have all been attributed to altered 
proliferation and survival tendencies when studied independently. Responses to these physiological stimuli 
are widespread and embedded into cell fate and phenotypic responses. Growth-induced stress is predicted 
to reach 18.9 kPa, though these measures were derived from excised tumors thus the impact of the 
surrounding ECM was negated and is thought to drive this compressive stress even higher42. Gene 
expression pathways shown to be influenced by the compressive environment include those linked to cell 
death, proliferation, cell attachment, and EMT182,185,186. Healthy cells typically halt proliferation as they 
sense their neighboring structures and a growing sense of compressive forces187. However, the specific 




in addition to the cell type. In the diseased state, cancer cells have been shown alter their proliferation 
tendencies though many studies provide contradictory findings188–190. Where some studies find compression 
an ineffective regulator of proliferation due to the dysregulation of the CHK2-p53 pathway and thus the 
inability to stimulate cell cycle arrest190, others suggest the treatment of cancer through the application of 
compressive forces to induce cell death191. Despite the conflicting evidence regarding proliferation, the 
tendency of compressive forces to drive infiltration and thus metastasis has been documented in several 
cancer cell types. In breast cancer under compression, the development of leader cells and invasive 
phenotypes was demonstrated185 , while migration in pancreatic and brain cancer cells was found to be 
arbitrated by GDF15 through the Akt pathway192 or the MEK1/Erk1 pathway186 respectively. The solid 
stress created in the tumor microenvironment has been linked to alternatively activating surrounding cells 
such as fibroblasts to assist in cancer cell migration as well193. Taken together, this solid stress compressive 
force may differentially affect cancer types, depending on their specific signaling cascades and mutations, 
but the impact and understanding of these responses is critical for advancing patient treatment.     
CDC42 is a Rho GTPase that acts as a molecular switch for a variety of cellular processes. It effects over 
20 downstream pathways and is influenced by over 30 promoters, inhibitors, and upstream regulators. Its 
overexpression is prevalent in a variety of cancers where it has been shown to influence proliferation, 
motility, polarity, growth, filopodia formation194, vesical trafficking, transcription, and cytokinesis195. Its 
role in mechanotransduction has been tied to matrix stiffness75 as well as tension-induced YAP pathway 
activation196, a well-known mechano-response cell signaling cascade197. CDC42 signaling in ovarian cancer 
has been associated with disease progression198, and is frequently overexpressed in primary ovarian tumor199 
though its association with mechanical stimulus is still unknown.  
Within ovarian cancer, the influences of mechanotransduction have been largely overlooked with a majority 
of studies focusing on shear stress stimulus stemming from the ascitic fluid movement37,200. The one study 




aggregates that would be found within the ascitic environment43. Thus, the lack of knowledge surrounding 
the influence of compression on ovarian cancer remains an area of critical need. 
In order to study compressive mechanotransduction in detail, we have developed a tunable 3D compression 
bioreactor. Ovarian cancer cells were subjected to static or cyclic compressive loads for 24 or 72 hours 
while encapsulated within a 3D agarose-collagen I hydrogel. Morphological changes, alongside 
proliferation and cell death were monitored in response to compressive stimulus revealing more 
proliferative and invasive phenotypes. Gene expression analysis was found to significantly upregulate 
CDC42 and the use of a CDC42 inhibitor was investigated independently and in combination with 
chemotherapeutic treatment. This compression system demonstrates the highly relevant mechano-sensitive 
response of ovarian cancer and its role in disease progression.   
4.2  Materials and Methods  
4.2.1 Cell Culture 
Cell culture reagents were purchased Thermo Fisher Scientific: RPMI growth medium (11875119), 
antibiotic/antimycotic (15240062), 0.25% trypsin-EDTA (25-200-056), rat tail collagen type I 
(344310001). Human ovarian cancer cell line OVCAR3 was purchased from American Type Culture 
Collection (ATCC, Manassas, VA) and ovarian cancer cell line OVSAHO was kindly provided as a gift 
from the Buckanovich lab (Magee-Womens Research Institute Pittsburgh PA). Low melt agarose was 
purchased from Boston Bioproducts Inc. (P73050G, Ashland, MA). Chemotherapeutic drugs Paclitaxel 
(T7402) and carboplatin (C0171) was purchased from Sigma-Aldrich (St. Louis, MO). Fetal bovine serum 
(FBS) was purchased from Gemini Bio-Products (100-106, West Sacramento, CA). 
Cells were plated on 15cm polystyrene plates with 1640 RPMI cell culture medium containing 10% FBS 
and 1% anti-anti until 80% confluency was reached. Cell cultures were maintained until use in the 




suspension at 10 million cells/mL in the combination 3% agarose 0.05% collagen-I hydrogel as previously 
described87.   
4.2.2 Device Construction and Use 
The following materials were used in the construction of the compression bioreactor: PDMS (0007604765 
Sylgard 184, Ellsworth Adhesives), carbon nanotubes (CNT) (030104, Cheaptubes.com, Grafton, VT ) 
silver epoxy (8331-14G, Electronic Parts Specialist, Flint, MI), 22 AWG single stranded wire (602-3051/1-
100-01, Mouser Electronics), 1/8 inch male luer locks (5121K151, McMaster-Carr), tubing (5195T62, 
McMaster-Carr). The compression bioreactor was made from PDMS (1:8 curing agent to PDMS ratio) 
molded over metal constructs to create the negative culture wells and air chambers as shown in Figure 13 
in two parts. The upper half of the reactor includes the cell culture well and medium reservoir while the 
lower portion contains the air pressure chamber and air inlet tube.  Deflecting membranes were generally 
modeled after the work done by MacQueen et al.201, made from carbon nanotube and PDMS (1:8 weight 
ratio) combined with a 1:10 curing agent weight ratio. The PDMS/curing agent/CNT mixture was then spin 
coated onto salinized glass slides to a thickness of 0.5 mm. The resulting membranes had a Youngs modulus 
of 248 kPa as determined through tensile testing on the TA XT Texture Analyzer (Van Vlack Laboratory 
University of Michigan, Supplemental Figure 9). The coated slides were allowed to cure at 40°C overnight 
before use. Membranes were then checked for conductivity, removed from the glass slide, placed over the 
air pressure chamber and sealed to the PDMS molds of the lower air chamber using 1:8 PDMS and this was 
once again cured overnight at 40°C. Silver epoxy was then used to connect wire to either end of the 
conductive membrane and this was allowed to cure. The upper PDMS construct was then fitted atop the 
constructed lower portion using 1:8 PDMS and allowed to cure. Finally, the double male ended tubing 
connector was fitted into the air inlet chamber and the entire construct was autoclaved for sterilization 
before use.  
Cell laden hydrogel constructs were placed in the compression and control chambers of the bioreactor and 




duration of the experiment. Each compression test included a matched, non-stimulated, control condition. 
Thus static controls represent non stimulated controls run simultaneously with the static compression 
experiments and the cyclic controls represent the non-stimulated controls run concurrently with the cyclic 
compression experiments.  
Electrical Hardware and Software Programming 
LabVIEW programming was used to run and maintain desired compression functions. Compression 
application was monitored simultaneously through resistivity measurements, digital pressure sensor, and 
mechanical pressure sensor. The schematic of the entire compression bioreactor system is depicted in 
Supplemental Figure 7. 
The reactor was connected via tubing to the syringe pump actuator system which controlled the supplied 
pressure via linear actuator displacement of a syringe. The air pressure within the closed system was 
measured via a digital pressure gauge (Tygon Omega Sensor) which was used within the LabVIEW 
program to monitor force application.  
A DAQ board (NI USB 6008) was used to interface with the pressure driving linear actuator (L12-I, 
Firgelli), pressure gauge, and LabVIEW software. Each compression bioreactor was conditioned for three 
thirty regiments of cyclic pressure loading while monitoring the resistivity change in the membrane in order 
to get a run-in profile for each reactor. Sample resistivity response curves to static and cyclic pressure 
functions are provided in Supplemental Figure 8. Resistance of the membrane was correlated to membrane 
deflection and applied pressure to monitor applied compression throughout the duration of the experiment. 
20 kPa of maintained pressure was applied to static compression experiments and 20 ± 5 kPa of air pressure 
cycled sinusoidal at a frequency of 0.05 Hz was used for cyclic compression experiments.  
COMSOL Computational Analysis 
Hydrogel characteristics previously determined through SEM, porosimetery, and rheometry were used as 




values are given in Supplemental Figure 9. Solid stress physics was used to describe the application force 
and resultant stresses. Linear elastic material was used to describe both the hydrogel and membrane 
characteristics and an underlying boundary load was used to define the pressure application on the 
membrane.  
4.2.3 Morphological Cell Analysis and Immunohistochemistry  
Hematoxylin and eosin staining was performed for morphological analysis and slides were imaged using 
the Nikon E800 light microscope. Stained sections were partitioned into quadrants and a minimum of 3 
photos in each quadrant were taken at 40x magnification for analysis. Cellular morphology was quantified 
using a custom MATLAB R2019a program that detected and encompassed the perimeter of the cell and 
calculating cellular area, perimeter, circularity, roundness, and aspect ratio (Figure 14 and Supplemental 
Figure 10). These results were then used for comparison and statistical analysis of the experimental 
condition.   
Histological sections of experimental hydrogels were stained for cell death and proliferation quantification 
using a Casp-3 (PI700182, Fisher Scientific) and Ki67 (PA5-16785, Fisher Scientific) antibody respectively 
according to VECTASTAIN Elite ABC-HRP Kit (PK-6101, Vector Laboratories) IHC staining procedure. 
Three images per section were taken and quantified using ImageJ cell counter plugin.  
4.2.4 Gene Expression Analysis 
Gene expression changes were investigated through RT-qPCR for a variety of genes involved in metastasis, 
EMT, mechanotransduction, chemoresistance, and cancer stem cell markers. A full list of evaluated genes 
and expression levels can be found in Supplemental Table 1. RT-qPCR was performed using 96 well plates 
and Power SYBR Green PCR master mix (ILT4367659) on a 7900HT system through the DNA sequencing 
core at the University of Michigan. Significance was determined through the 2-ΔΔCT method comparing 




4.2.5 G-LISA Assay (CDC42 Activation and Inhibition) 
To assess CDC42 activation a G-LISA assay from Cytoskeleton Inc. (Cat. # BK127) was used. Sample 
preparation procedures were followed as directed in kit instructions with few modifications to accommodate 
3D cell culture hydrogels. Briefly, gels were crushed while submerged in the lysis buffer and lysate 
concentrations were equalized prior to addition to detection wells (protein lysate concentrations were 
increased to 2.5 mg/mL for CDC42 detection). Detection plate was placed on a cold orbital shaker for 15 
minutes, followed by appropriate washing and application of antigen presenting buffer, anti-Cdc42 primary 
antibody, secondary antibody, and HRP detection reagent, and HRP stop buffer (colorimetric development 
incubation time in the 37°C incubator was extended to 20 minutes). Signal was read immediately via a 
microplate spectrophotometer. Inhibition of CDC42 was achieved through the specific CDC42 inhibitor 
ML141 (Sigma-Aldrich 217708-25MG), 100 µM for 24 hours202. Reduction in CDC42 activation was 
monitored via the G-LISA colorimetric assay and results are shown in Supplemental Figure 12. 
4.2.6 Chemotherapeutic Treatment 
Drug treatment was performed using paclitaxel 10uM and carboplatin 250uM independently and 
simultaneously. Treatment concentrations were drawn from previously published studies on OVCAR3 cell 
death in response to carboplatin treatment203 and paclitaxel treatment of epithelial ovarian cancer cell 
lines204. Paclitaxel was diluted in DMSO and carboplatin was suspended in water before addition to cell 
culture medium within the compression bioreactor.  All chemotherapeutic drug experiments were 
performed on either control or statically loaded hydrogels.  
4.2.7 Statistical Analysis 
Three biological replicates were performed for each experiment with three technical replicates in each run. 
Statistical analysis and graphical plots were constructed in GraphPad Prism 6 (www.graphpad.com, San 
Diego, CA) software using either one-way ANOVA or t-test. All data are displayed as mean ± SEM. 
Significance in gene regulation was defined as greater than a twofold increase (2) or a twofold decrease 




4.3  Results 
4.3.1 COMSOL Compression Bioreactor Bodel Shows Pressure Distribution within Hydrogel 
To predict the compressive forces experienced by ovarian cancer cells encapsulated within the hydrogel a 
COMSOL model was constructed of the hydrogel and force applying deflection membrane. A sample mesh 
of the model is provided in Figure 13D and the corresponding mesh analysis can be found in Supplemental 
Figure 9. Von Mises stress distribution throughout the hydrogel was found to apply an average compressive 
force of 5.2 kPa to encapsulated cells and vary from 3.9 – 6.5 kPa under cyclic loading regiments (Figure 
13E). Although greater compressive forces were observed at the contacting face of the hydrogel-membrane, 
cellular responses were averaged throughout the entirety of the hydrogel and so the output compressive 





Figure 13: Compression bioreactor schematic and computational model. 
A. SolidWorks rendering of compression bioreactor. Air is pumped into the underlying pressure 
chamber which deflects into the hydrogel cell culture. The hydrogel cell culture is held in place via 
a porous acrylic plug which also allows media access from the above cell culture growth medium 
chamber.  
B. Isometric view of example compression bioreactor. 
C. Front view of example compression bioreactor with air pressure applied to show deflection of 
resistivity sensing membrane (black dome) 
D. Mesh construction on COMSOL model of hydrogel and deflectable membrane.  
E. Sample output of COMSOL analysis showing center slice through z-y plane. Deformation of the 
membrane and hydrogel are shown with an applied pressure of 20 kPa. Average compressive stress 





4.3.2 Compression Induces Invasive Morphology in Ovarian Cancer Cells 
The shape of a cell is a known indicator of cellular fate and migratory intension thus morphological analysis 
was performed to evaluate the influence of compressive stimulus via H&E staining. Cellular morphology 
was significantly altered in response to compressive stimulus. Cells showed an increase in aspect ratio as 
quantified via H&E staining (Figure 14). A significant increase in aspect ratio was also seen in statically 
compressed vs. cyclically compressed OVCAR3 cells for both the 24 hour and 72 hour timepoints. 
Additional quantification of cellular area, perimeter, circularity, and roundness can be found in 
Supplemental Figure 10. This elongation of the cell is indicative of an invasive phenotype and likelihood 
of cellular metastasis. 
 
Figure 14: Morphological change of ovarian cancer cells under compression indicate invasiveness. 
A. 24 hour compressive stimulation of OVCAR3 cells under static or cyclic loading.  
B. 24 hour compressive stimulation of OVSHAO cells under static or cyclic loading.  
C. 72 hour compressive stimulation of OVCAR3 cells under static or cyclic loading.  
D. Exemplary images of cellular morphology under control, static, or cyclic loading conditions. 





4.3.3 Compression Enhances Ovarian Cancer Proliferation and Reduces Cell Death 
Changes in cellular morphology is a known influencer of cellular proliferation and survival165 and a critical 
component to cancer progression. Thus, how ovarian cancer altered proliferation tendencies and cell death 
in response to cyclic and static compressive stimulus was evaluated. Cells subjected to compression 
displayed a significant increase in proliferation marker Ki67 as well as a reduction in cell death marker 
cleaved caspase-3. This trend held for all forms of compressive stimulus in both cell lines (Figure 14) 
although these trends were not significantly maintained for the 72hr time point (Supplemental Figure 11).   
 
Figure 15: Proliferation, cell death, and gene regulation changes in response to 24 hours of static or cyclic 
compressive stimulus. 
Star indicators located directly above a column indicates significant change when compared to the non-
drug treated condition.  
A. Cellular proliferation of OVCAR3 cells under static and cyclic compressive conditioning.  
B. Cellular proliferation of OVSAHO cells under static and cyclic compressive conditioning.  
C. Cell death of OVCAR3 cells under static and cyclic compressive conditioning.  
D. Cell death of OVSAHO cells under static and cyclic compressive conditioning.  
E. Gene expression changes via RT-qPCR for CDC42, ABCB1, ABCG2, and OCT4. Cells were 
stimulated for 24 hours under static or cyclic conditions. A two fold upregulation is indicated by 
the dotted line.  





4.3.4 Compression Induces Overexpression of CDC42 
To understand by which mechanism the compressive stress induced mechanotransduction may be 
regulating alterations in proliferation, cell death, and morphology we ran a RT-qPCR analysis on a wide 
variety of genes known to be involved in mechanotransduction, metastasis, cancer stem cells, EMT, and 
ovarian cancer (Supplemental Table 1). A significant upregulation of CDC42 was found in both cell types 
for both static and cyclic compressive stimulus. Additionally, upregulation of known chemotherapeutic 
efflux pumps, ABCB1 and ABCG2, was observed when compared to non-stimulated controls though this 
change was not significant in all conditions. Interestingly, significant upregulation of stem cell marker 
OCT4 was observed in both cell types but only under static compression conditioning indicating a stimulus 
specific response to compression loading regimes.  
4.3.5 Chemoresistance is Observed Under Compression 
Due to the upregulation of chemoresistance genes observed in the RT-qPCR array we next investigated the 
cellular response to clinically used chemotherapeutics paclitaxel and carboplatin. A slight reduction in cell 
death was observed for OVCAR3 cells under compression when treated with independent or dual drug 
treatment though only paclitaxel showed a significant reduction in cell death of cells under compression 
(Figure 16A). OVSAHO cells showed a significant reduction in cell death in response to chemotherapy for 
all treatment regiments when under compression indicating chemoresistance (Figure 16B). Cellular 
proliferation for both cell lines was significantly reduced with chemotherapeutic treatment and no 






Figure 16:  Cell death and proliferation rates in response to chemotherapeutic treatments, inhibitor 
therapy, and simultaneous administration show chemoresistance is mitigated by combination therapy. 
Star indicators located directly above a column indicates significant change when compared to the non-
drug treated condition.  
A. OVCAR3 cellular death rates in response to paclitaxel, carboplatin, and combination treatments. 
Significant reduction in cell death is observed under compressive paclitaxel treatment.   
B. OVSAHO cellular death response to chemotherapeutic treatments. Significant reduction in cell 
death is observed in all compression conditions when compared to non stimulated controls. 
C. OVCAR3 proliferation responses to chemotherapeutic treatments. Drug treatments effectively 




D. OVSAHO proliferation responses to chemotherapeutic treatments show compression induced 
proliferation enhancement effectively mitigated by drug administration. 
E. OVCAR3 proliferation response to CDC42 inhibitor treatment, dual drug chemotherapy, and 
combined treatment.  
F. OVCAR3 cellular death rates in response to CDC42 inhibitor treatment, dual drug treatment, and 
combination therapy. Combination therapy more effectively targets proliferating cells and 
improves cell death count compared to either treatment alone. 
(Significance calculated via t-test; ****p< 0.0001, ***p< 0.001, **p< 0.01, *p< 0.1, n≥3 experiments) 
 
4.3.6 Inhibition of CDC42 Reduces Compression-Induced Proliferation, Cell Survival, and 
Chemoresistance 
Due to the upregulation of CDC42 observed in the RT-qPCR, we hypothesized the phenotypic changes 
observed under compression may relying on CDC42 activity. CDC42 activation was first quantified using 
the Cytoskeleton G-LISA assay (Supplemental Figure 12) which confirmed the increased level of activated 
GTP bound CDC42 under compressive stimulus. We then investigated the effective use of CDC42 specific 
nucleotide binding inhibitor ML141 which showed a 66% reduction in active GTP bound CDC42 with 
100uM treatment (Supplemental Figure 12).  
Since CDC42 is such a widespread effector and is a known influencer of cell cycle progression we 
investigated the impact of inhibition on proliferation and cell death tendencies under compressive stimulus. 
IHC staining showed a significant reduction in cellular proliferation as well as an increase in cell death for 
both stimulated and control cells alike (Figure 16E). Cellular death was significantly lower in inhibited-
compression samples compared to inhibited-control samples though both cellular death levels were 
significantly increased when compared to non-inhibited controls (Figure 16F).  
With combination therapy of dual drug treatment and ML141 a significant increase in cell death was 
observed compared to either treatment independently (Figure 16F). Additionally, the number of 
proliferating cells was significantly reduced with combination therapy compared to dual drug treatment 
alone (Figure 16E). This indicates the chemoresistant effect observed under compressive stress can be 
overcome and treatment effectiveness may be enhanced through combination therapy when compared to 




4.3.7 Cellular Area is Significantly Increased with CDC42 Inhibition and Dual Drug Treatment, 
but Invasive Potential is Maintained 
Since CDC42 has been identified as a contributor to cellular morphology, we investigated both inhibitor 
and drug treatment effects on cell shape (Supplemental Figure 13). The most significant changes were 
observed with simultaneous inhibitor and drug treatment with cellular area significantly increasing for both 
control and compressed cells. Under compression the aspect ratio of the cells was maintained significantly 
higher than controls for dual drug treatment, inhibitor treatment, and combination therapy (Supplemental 
Figure 13) implying compression induced invasive morphology is not solely dictated by CDC42 activation.  
4.4  Discussion 
Ovarian cancer experiences a unique microenvironment subjected to both transient and static compressive 
forces, an aspect of the disease that has yet to be thoroughly explored. The mechanical forces that cells 
experience play a major role in their fate and understanding how mechanotransduction influences cancer 
progression will aid in the treatment of disease. In order to study this overlooked feature, we have designed 
and constructed a tunable 3D compression bioreactor.   
Computational modeling using COMSOL Multiphysics determined cells experienced an average 
compressive force of 5.2 kPa from an applied deflective pressure of 20 kPa to the resistivity sensing 
membrane. This stimulus value is on the lower end of predicted compressive forces experienced by the 
primary tumor in vivo. Static loads of 5.2 kPa and cyclic loads of 5.2 ± 1.6 kPa applied for 24 to 72 hours 
increased the proliferative potential of ovarian cancer cell lines while decreasing overall cell death. This 
seems to imply a feed forward mechanism where tumor growth enhances compressive forces, which further 
simulate tumor proliferation. Previous studies concerning other cancer cell types under compression did 
not observe changes in proliferative potential185 indicating a unique phenotypic change for ovarian cancer 
cells under this stimulus. The morphological alteration of the cells under compressive stimulus for static, 
cyclic, 24, and 72 hours of loading show elongation of the cells indicating invasive potential. Surprisingly, 




static loading enhanced the aspect ratio of the OVCAR3 cells when compared to cyclic loading although 
both loading functions significantly increased elongation compared to controls. This shows that static and 
cyclic loading similarly impacts phenotypic changes at this loading regiment.  
For both cell types and compressive loading functions CDC42 upregulation was observed. CDC42 has 
previously been shown to regulate mechanotransduction responses such as endothelial migration205,206, 
osteoblast β-catenin signaling207, integrin signaling208, morphology and differentiation of mesenchymal 
stem cells209, and stiffness induced dormancy of cancer cells75. However, it has not yet been tied to ovarian 
cancer mechanotransduction. It seems little difference was observed in gene changes between static and 
cyclic loading cycles beyond OCT4 upregulation in static compression and slight downregulation with 
cyclic loading. OCT4 is a stem cell like marker often overexpressed in cancers and tied to enhanced ovarian 
cancer proliferation, reduced apoptosis, and chemoresistance210,211.  Though further analysis of the OCT4 
pathway and comparison of cyclic vs static stimulus was not performed it would be an interesting topic for 
future studies.  
Drug treatment responses under compression showed a tendency toward chemoresistance though this 
difference was only significant for OVCAR3 paclitaxel treatment and all OVSAHO chemotherapy 
treatments. Dual drug treatment did significantly increase cell death compared to non-drug treated controls 
however with the inclusion of CDC42 inhibitor treatment the drug response was further enhanced, elevating 
cell death levels above chemotherapeutics alone. With the inclusion of a CDC42 specific inhibitor the 
proliferation counts for both control and compressed conditions were significantly reduced and in 
combination with carboplatin and paclitaxel treatment proliferation was decreased even further. These 
findings support the proposed use of CDC42 inhibitors in combination with chemotherapy for improved 
patient treatments as suggested for several other cancer types212 though no known clinical trials for this 
combination therapy currently exist.   
Taken together these results demonstrate the use of this dynamic compression bioreactor for the 




stimulus significantly alters ovarian cancer cell phenotype and plays a major role in the progression of the 
disease. Dual treatment of CDC42 inhibitors alongside standard chemotherapeutics improves cell death 
counts while reducing proliferation, a promising avenue for patient treatments in the future (Figure 17).  
 
Figure 17: Summary of ovarian cancer response to compressive stimulus within a 3D agarose-collagen I 
hydrogel. 
4.5  Conclusion 
In conclusion we have developed a tunable compression bioreactor for 3D cell culture. The reactor is 
capable of programmable compression functions as well as static loading which is continuously monitored 
via LabVIEW programming. This self-maintaining system was shown to be useful for extended cultures up 
to 72 hours and is widely applicable for a variety of cell types. Here we show that ovarian cancer cells under 
physiological compressive stimulus enhance their invasive potential, proliferative capacity, reduced 
apoptosis, and obtained chemoresistance. Additionally, ovarian cancer upregulates CDC42 significantly 
and consistently across cell type and stimulus program. Inhibition of CDC42 resulted in the mitigation of 
enhanced proliferation, and resistance to chemotherapy although invasive morphology was maintained. 
Overall, this compression bioreactor demonstrates the importance of physiological compressive stimulus 






CHAPTER 5: Ovarian Cancer Cells Under Shear Stress Increase Proliferation, Invasion, and 
Chemoresistance
5.1  Introduction 
The U.S. population saw over 22 thousand new diagnosis of ovarian cancer in 2019, with nearly 14 thousand 
deaths due to this disease. The five year survival rate is 29% for those diagnosed at stages with distant 
metastasis, and 57% of ovarian cancer patients are diagnosed at these late stages3. One reason for this poor 
prognosis is that patients are unaware of their condition as ovarian cancer is largely asymptomatic until late 
stages. One symptom and side effect that nearly 30% of patients develop is the retainment of fluid within 
the peritoneal cavity, known as ascites. Where normal physiology allows for the filtration and maintenance 
of small fluid volumes within the cavity, the diseased state tends to clog the lymphatic drainage and increase 
permeability of the peritoneum. These changes allow for cellular infiltration and buildup of fluid where it 
normally would not be retained19,213. As the ovaries are located within the peritoneal cavity, this fluid 
accumulation significantly alters the microenvironment of the primary tumor.        
Ascitic fluid is not stable within the peritoneal cavity. As patients move throughout their daily lives the 
fluid moves as well. For example, when going from a prone to upright position, gravity causes redistribution 
of the liquid. Likewise, breathing and organ movements from digestion cause fluid flow with the cavity214. 
This dynamic flow stimulates the ovaries and interior of the peritoneal cavity with shear stress39. The impact 
of the mechanical environment on downstream signaling cascades and phenotypic changes is known as 
mechanotransduction. How this shear stress stimulus alters the ovarian cancer microenvironment and aid 




Clinically there have been no direct measurements of the shear stress magnitude within the peritoneal 
cavity. Typical patient treatment for ovarian cancer includes drainage of the ascitic fluid, where some 
internal pressure measures can be made, followed by chemotherapeutic treatment sometimes administered 
directly within the cavity. This method of administration helps to target not only the primary tumor directly 
but also the potential tumor cells that may have sheared off the ovary into the ascitic fluid215. Dissemination 
of exfoliated cancer cells within the peritoneal cavity is one primary mechanism of ovarian cancer 
metastasis, known as trancoelomic metastasis41,215. With this mechanical force being such a prominent 
mechanism in the spread of the disease, it is also predicted to heavily influence the phenotypes and cell 
selections of the metastatic spheroids as well as the primary tumor growth and behavior216. However, due 
to the inherent lack of physiological measures of the shear stress magnitude, model estimates have been 
used to predict the shear stress ranges achieved in vivo to range anywhere from 0 – 11 dynes/cm2, though 
this value would be dependent on patient physiology and ascitic fluid volume102,217. This is an area of 
research that desperately needs attention if we are to continue to improve and create in vitro systems  that 
replicate true physiology.   
Knowledge of this shear stress stimulus on ovarian cancer cells has not gone unexplored. Several variations 
on devices used to investigate this mechanical stimulus have been created. The findings so far have shown 
an overall increase in aggressive cell phenotypes such as epithelial to mesenchymal transition39, an 
upregulation of stem cell markers, chemoresistance37, and cytoskeletal rearrangement such as stress fiber 
formation102. The mechanotransduction of shear stress stimulus has also been known to influence gene 
expression changes and therapeutic response100,162. However, many of these shear stress devices fail to 
consider the three-dimensional microenvironment and the full range of shear stress forces that cells could 
be experiencing.  
MUC15 is a transmembrane glycoprotein that plays a role in a variety of cellular mechanisms such as 
adhesion, proliferation, migration, and invasion218,219. It has been found to have a significantly altered 




However, it is unique in that expression levels are not consistent between cancer types. This means that 
although overexpression of MUC15 may be correlated to poor outcomes in diseases like glioma220, 
thyroid221, and colon cancers222 this trend does not hold for all cancer types. For example, in 
hepatocellular223 and kidney carcinomas220 down regulation of MUC15 is associated with short term 
survival and aggression of the disease. This irregularity in MUC15 expression between cancers 
demonstrates the importance of cell type and physical location on cellular responses. The MUC15 pathway 
is largely understudied. Investigations in thyroid cancer indicate MUC15 acts through ERK (extracellular 
signal-regulated kinase) and integrin-focal adhesion kinase pathways to induce stemness and tumor 
progression221.  There exists little to no consideration of its effects in ovarian cancer or its prognostic 
potential220. As it is a transmembrane protein it has the potential to sense the surrounding microenvironment 
and convey signaling cascades to the interior of the cell. Additionally, the regulation of cancer stem cell 
factors224 are of critical importance to ovarian cancer’s ability to form surviving spheroids in the ascites and 
enable transcoelomic metastasis216.  
In order to investigate this unique microenvironment and reliably stimulate 3D cell cultures with a wide 
range of shear stress stimulus, we modified and improved our previous shear stress bioreactor156,162. 
Specification of design changes can be found in materials and methods. High grade serous ovarian cancer 
cell lines, OVCAR3 and OVSAHO, were encapsulated within a 3D combination agarose/collagen hydrogel. 
3D cell cultures were then stimulated within the bioreactor for 24 hours with 1, 5, or 11 dynes/cm2 of shear 
stress stimulus. Mechanically stimulated cells displayed an invasive phenotype, heightened proliferation, 
chemoresistance, and a consistent downregulation of MUC15. The impact of MUC15 regulation was 
investigated using shRNA and overexpression vectors in combination with shear stress stimulus. Overall, 
shear stress stimulus aids in the progression of ovarian cancer and is an important factor in 
mechanotransduction response of the cells. Additionally, MUC15 may be an important indicator of disease 




5.2 Materials and Methods 
5.2.1 Cell Culture 
Purchases of cell culture reagents were primarily obtained through Thermo Fisher Scientific: RPMI growth 
medium (11875119), antibiotic/antimycotic (15240062), 0.25% trypsin-EDTA (25-200-056), rat tail 
collagen type I (344310001). The cell line OVCAR3, was obtained from American Type Culture Collection 
(ATCC, Manassas, VA) and the OVSAHO cell line was donated by the Buckanovich lab (Magee-Womens 
Research Institute Pittsburgh PA). Agarose used for hydrogel construction was purchased from Boston 
Bioproducts Inc. (P73050G, Ashland, MA). Drug treatment reagents paclitaxel (T7402) and carboplatin 
(C0171) were purchased from Sigma-Aldrich (St. Louis, MO). Fetal bovine serum (FBS) was purchased 
from Gemini Bio-Products (100-106, West Sacramento, CA).  
Standard cell culture practices were followed, culturing on 15cm polystyrene plates with 1640 RPMI 
medium supplemented with 10% FBS and 1% anti-anti. Cells were passaged once 80% confluency was 
reached. Cells were collected using 0.25% trypsin, pelleted and resuspended at a concentration of 10 million 
cells/mL within the combination (3% agarose 0.05% collagen 1) hydrogel as previously described87.   
5.2.2 Bru-seq 
Two shear stress experiments with corresponding static controls were performed for 24 hours using 
OVSAHO cells. After 24 hours of stimulus, 5-bromouridine (850187, Sigma-Aldrich) was added to the cell 
culture medium for a concentration of 2 mMol/L. The shear stress stimulus or static incubation was 
continued for 30 minutes before takedown and RNA extraction. RNA was then submitted to the Bruseq 
center at the University of Michigan for sequencing (University of Michigan DNA Sequencing Core) and 
analysis (1410 B520 NCRC,  Ljungman Lab, University of Michigan). The resulting 6 most upregulated 
and 6 most down regulated genes were then probed via RT-qPCR for confirmation of expression changes.   
5.2.3 RT-qPCR 
Alterations in gene expression profiles were tested for a plethora of genes involved in EMT, 




complete listing of investigated genes and their corresponding expression levels are provided in 
Supplemental Table 1. RT-PCR was performed on a 7900HT system through the DNA sequencing core at 
the University of Michigan. Fold change in regulation was determined through the 2-ΔΔCT method 
comparing the compression stimulated cells to their corresponding controls 133.  
5.2.4 Immuno-blotting for MUC15 
Sheared hydrogels were harvested and lysed in 200 μl of Radio-immunoprecipitation assay (RIPA) Buffer, 
sonicated for 30s on ice with a probe sonicator. Extracted concentration was measured using the BCA Assay 
Reagent (Pierce) following manufacturer’s protocol for a 96-well format. Subsequently, 50 μg of protein 
from each sample was loaded onto 4–20% gradient polyacrylamide gels (Biorad), and separated 
electrophoretically, transferred to a PVDF membrane. Transferred membranes were blocked with 5% non-
fat milk and probed with mucin-15 (PA5-48498, Fisher Scientific) overnight at 4 °C, washed with TBST 
buffer, and probed with an appropriate HRP conjugated secondary antibody. β-Actin was used as a loading 
control to determine changes in mucin-15 expression among samples. ECL reagent (Pierce Protein Biology) 
was used to visualize bands in a Biorad ChemiDoc Touch instrument. Digital images acquired were 
processed through Image Lab 6.0.1, and band analysis tools were used for densitometry. Band densities 
were normalized against the loading control β-Actin, to determine changes. 
5.2.5 Shear Stress Bioreactor Design Alterations 
A few significant design modifications were made to the previously described shear stress bioreactor162. 
First additional flow chamber space was added at the entry and exit site of the circulating medium prior to 
entry within the hydrogel stack (Supplemental Figure 14). A notch was inserted within the wall of the 
hydrogel stack chamber for easy access and removal of hydrogel stack components post experimentation. 
To avoid extraneous fluid flow, the notches were fitted with removable stainless-steel rods for the duration 
of shear stress application. The radial flow chambers were left unobstructed and shear stress rates were 
modulated solely by peristaltic pump settings. Finally, the entire shear stress bioreactor was machined from 




durability and experiment turnover via autoclave sterilization. All alterations in bioreactor design were 
included in the updated COMSOL model for an accurate depiction of fluid flow velocities within the 
hydrogel.  
5.2.6 Computational Analysis of Shear Stress 
A numerical model was constructed of the 3D shear bioreactor using COMSOL Multiphysics 5.3 as 
previously described87. Briefly, the average velocity magnitude was determined within the hydrogel 
construct of the model. This velocity value was then used in a sequential model to estimate the peak shear 
stresses experienced by a single cell within the hydrogel via laminar flow physics. Mesh analysis was 
performed to ensure an adequate element number was used (Supplemental Figure 14B). 
5.2.7 Immunohistochemistry 
The following reagents needed for immunocytochemistry were purchased from Invitrogen (Carlsbad, CA): 
formalin, Goat serum, Triton‐X, bovine serum albumin), phosphate‐buffered saline, ProLong Gold 
Antifade Mountant. The anti‐Ki‐67 antibody (PA5‐16785), anti‐ Caspase‐3 antibody (700182), and citrate 
buffer were purchased from Thermo Fisher Scientific (BDB558615, Pittsburgh, PA). Vectastain elite ABC‐
HRP kit, DAB, Hematoxylin, and Bloxall solution were purchased from Vector laboratories (Burlingame, 
CA). 
5.2.8 Imaging and Quantification 
Histology sections were stained with hematoxylin and eosin for morphological analysis. Resulting stains 
were imaged at 40x using the Nikon E800 light microscope. Quantification of cellular area, perimeter, 
circularity, roundness and aspect ratio was determined from these images via a custom MATLAB R2019a 
program (Supplemental Figure 15, Figure 19). IHC staining for Ki67 (PA5-16785, Fisher Scientific) and 
cleaved caspase-3 (PI700182, Fisher Scientific) was performed using the Vectastain Elite Kit (PK-6101, 
Vector Laboratories) for quantification of cellular proliferation and death levels respectively. A minimum 




5.2.9 Mouse Models  
Experimental gels were first cut into small pieces using a cell scraper. Cell laden hydrogel pieces were then 
degraded through enzyme digestion using 100U agarase (A6306-5KU, Sigma-Aldrich) in 500 uL of media. 
This mixture was then incubated at 37°C for 30 minutes before mechanical disruption via pipetting. Cell-
gel slurry was then passed through a 40 um filter and flow through was spun down. The resulting pellet 
consisted of pipette-able agarose-cell mixture which was then injected subcutaneously in male NSG mice 
from Jackson Labs. One million cells per injection were administered, one on each flank and 3 mice per 
experimental group (two experimental groups: control and shear stress stimulated (5 dyne/cm2)). The mice 
were provided by the Difeo lab at the University of Michigan.  
5.2.10 Statistical Analysis 
GraphPad Prism 7 (San Diego, CA) software using either one-way Anova or t-test and all graphical data 
are displayed as mean ± SEM. Significance in gene regulation was defined as greater than a twofold change 
in expression. Three biological replicates were performed for each condition with three technical replicates 
of controls and eight technical replicates of shear in each run. Statistical analysis and graphical plots were 
constructed in GraphPad Prism 6. 
5.3  Results 
5.3.1  COMSOL Modeling Determines Applied Shear Stress Values 
In order to obtain the desired shear stress values of 1, 5, and 11 dynes/cm2 within the shear stress bioreactor 
a two part model system was used as previously described162 via COMSOL software. This two-part model 
system was used in reverse in order to back calculate the necessary pump settings to achieve the shear stress 
values on the perimeter of the cell. Results from the two-part model concluded that pump settings of 13, 
60, and 122 correlated to resulting flow rates of 0.041, 0.188, 0.376 mm/s. This provided the averaged flow 
velocity within the hydrogel construct of 0.78, 3.66, 7.34 mm/s. These values sequentially used in the 
secondary model provided maximal output shear stresses of 1, 5, and 11 dynes/cm2. These levels of shear 




results are provided in Figure 18. Additionally, the modifications made to the bioreactor design, as 
described in materials and methods, provided well distributed fluid velocity throughout the hydrogel 
(Supplemental Figure 14).  
 
Figure 18: Sher stress bioreactor schematic and COMSOL model. 
A. Open face view of the shear stress flow plate. Fluid flows into the center well, down the radial flow 
chambers, and then in through the hydrogel stacks. Circular notches at the edge of each hydrogel 
stack house stainless steel rods for the duration of the experiment which are then removed to allow 
access and removal of the cell laden hydrogel.  
B. Constructed side view of the shear stress bioreactor. PDMS seals and stainless steel endplates are 
bolted together with the flow plate to provide a closed system, accessed by the flow inlet and outlet 
nozzles.  
C. Solidworks rendering of the shear stress bioreactor flow plate. Cell culture medium flow travels in 
to the center well, down the radial flow channels, through the hydrogel stacks, then out the other 
side of the flow plate. 
D. COMSOL rendering of the fluid flow velocity through the shear stress bioreactor (primary model). 
E. Resultant shear stress values from secondary COMSOL model demonstrate the goal shear stresses 
of 1, 5, and 11 dynes/cm
2
 are attained.  
 
5.3.2 Shear Stress Stimulus Induces Invasive Morphology of Ovarian Cancer Cells 
Morphological analysis was performed via H&E staining on control and shear stress stimulated cell laden 




and elongation. This marked change in cell shape indicates an invasive morphology under shear stress for 
both cell types (Figure 19). Surprisingly, a significant increase in aspect ratio was not observed for 
OVCAR3 cells at 5 dynes/cm2 simulation or OVSAHO cells under 1 dyne/cm2 simulation though trends 
were maintained.  
5.3.3 Enhanced Proliferation is Observed in Ovarian Cancer Cells Under Shear Stress Stimulus 
Due to the relation of cellular morphology and cell cycle progression and survival, we next investigated the 
impacts of shear stress stimulation on proliferation. For this purpose, we performed IHC staining for 
proliferation marker Ki67. Tallied results showed enhanced proliferative potential under 11 dynes/cm2 of 
shear stress stimulation and level of enhancement showed some tie to shear stress intensity. For OVSAHO 
cells, all levels of shear stress induce significant increase in proliferation with 5 dynes/cm2 showing the 
most market increase (Figure 19). This may indicate a response proportional to the stimulus though 





Figure 19: Shear stress stimulus alters morphology and proliferation of ovarian cancer cells. 
A. OVCAR3 cellular area at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
B. OVSAHO cellular area at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
C. OVCAR3 cellular aspect ratio at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
D. OVSAHO cellular aspect ratio at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
E. OVCAR3 cellular proliferation at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
F. OVSAHO cellular proliferation at 1, 5, and 11 dynes/cm2 of shear stress stimulus.  
(Significance calculated via one-way ANOVA for morphological analysis and t-test for proliferation 





5.3.4 Shear Stress Induces Slight Chemoresistance in Ovarian Cancer Cells 
As chemoresistance has been shown in previous studies with shear stress stimulus, we next investigated 
cell death rates under chemotherapeutic treatment using paclitaxel and carboplatin, standard ovarian cancer 
therapeutics. Only OVCAR3 cells showed a significant decrease in cell death while under drug treatment 
and shear stress stimulation. OVSAHO cells showed no change (Figure 20).  
5.3.5 Ovarian Cancer Cells Under Shear Stress Stimulus Under-Express MUC15 
To evaluate the impact of shear stress on alterations in gene expression a Bru-seq analysis was performed 
on OVSAHO cells. The resulting 6 most highly upregulated and most downregulated where then probed 
through RT-qPCR on both cell lines for each shear stress value. In addition to these, a variety of genes 
involved in cancer metastasis, cancer stem cell markers, and chemoresistance were also probed for changes 
in regulation. Resulting gene expression level changes are provided in Supplemental Table 2.  Of the genes 
investigated via RT-qPCR little consistency was observed between cell types and stimuli levels. The only 
consistent change across all investigated conditions was the universal downregulation of MUC15 (Figure 





Figure 20: Chemotherapeutic response and altered MUC15 expression of ovarian cancer cells under shear 
stress stimulus. 
A. OVCAR3 cell death response to paclitaxel and carboplatin therapy under shear stress stimulus. 
B. OVSAHO cell death response to paclitaxel and carboplatin therapy under shear stress stimulus. 
C. RT-qPCR analysis of MUC15 regulation under shear stress stimulus. Two-fold decrease in 
regulation is indicated by red dotted line. All values are normalized to their own controls which 
have an expression level of 1.  
D. Western blot quantification of MUC15 protein levels in response to shear stress stimulus.  
(Significance calculated via t-test for panels A, B, and D ****p< 0.0001, ***p< 0.001, **p< 0.01, *p< 0.1, 
n≥3 experiments) 
 
5.3.6 In Vivo Studies of Shear Stress Stimulated Cells 
To assess the translatability of these shear stress studies to in vivo responses, hydrogels post stimulation 
were degraded using agarase to extract OVCAR3 cells. The shear stress stimulated cells, and respective 3D 
cultured controls, were then injected subcutaneously for assessment of tumor formation and growth rate. It 




the observed enhanced proliferation rates. However, no decisive conclusions could be made (Figure 21). 
This may be due to a variation in cell count per injection, as the cell recovery gel degradation protocol 
produced a highly viscus working solution.   
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Figure 21: Tumor growth rates in murine model injections. 
Due to difficulty in cell extraction from hydrogels, injection cell counts were not homogeneous and thus no 
discernable trend in tumor growth rate was found.  
 
5.4  Discussion 
The use of this improved bioreactor design enabled uniform shear stress stimulus to cells encapsulated 
within the 3D hydrogel at 1, 5, and 11 dynes/cm2. Due to the incorporation of an empty chamber before the 
porous plug of the hydrogel stack, velocity vectors were able to equilibrate before passing uniformly 
through the hydrogel. Additionally, a major beneficial alteration in the bioreactor design was the use of a 
cylindrical notch incorporated into the wall of the hydrogel stack, filled by a metal rod throughout the 




hydrogel. Finally, construction of the shear stress bioreactor from stainless steel enabled quick and easy 
turnover time between experiments as sterilization could be performed via autoclave.   
Cells showed alterations in their morphology at all shear stress levels, similar to changes observed in our 
previous studies on breast cancer156,162. Cells increased their cross sectional area while also elongating 
indicating intent to invade and metastasize. In addition to altering physical appearances, the proportion of 
cells proliferating, as indicated by Ki67 expression, was substantially enhanced. However, response levels 
appear to be dependent on both cell type as well as magnitude of shear stress applied.  
Cells stimulated with 11 dynes/cm2 were treated with dual paclitaxel and carboplatin chemotherapy. When 
cell death rates were compared to non-stimulated drug treated controls once again a reduction in cell death 
was observed but only for the OVCAR3 cell line. These differences in response to treatment may stem from 
the differences between cell lines. OVCAR3 are derived from malignant ascites of a Caucasian patient with 
progressive adenocarcinoma of the ovary225. They express the androgen receptor, estrogen receptor, and 
progesterone receptor. OVSAHO cells are derived from an abdominal metastatic site of a Japanese patient 
with ovarian adenocarcinoma stage IIIc that had previously been treated226. When their genomic profile 
was compared227, OVCAR3 cells were classified as possibly high-grade serous ovarian cancer while 
OVSAHO was classified as likely high-grade serous ovarian cancer.  Where OVCAR3 is one of the most 
highly cited cell lines for high grade serous ovarian cancer (HGSOC), OVSAHO is rarely used for HGSOC 
experimentation. Additionally, alteration in some critical genes are reported between the two lines, 
OVSAHO has BRCA2 and RB1 (tumor suppressors) homozygous deletions while OVCAR3 has 
amplifications of CCNE1 and C11orf30 (tied to causes of ovarian cancer)227. OVSAHO is reported to have 
low functional activity in terms of migration, invasion, proliferation, EMT phenotype etc228. Both OVCAR3 
and OVSAHO do form xenografts with HGSOC histology229. Though no single property of these cell lines 
specifically accounts for the alteration in their response to shear stress stimulus, our findings alongside the 
comparative work of others shows the massive impact cellular heterogeneity can have on patient response 




Taking into account the differences that define the individual OVSAHO and OVCAR3 cell lines, it is 
surprising that a uniform and consistent alteration in the MUC15 expression was found for all shear stimuli 
among all cells. MUC15 is a transmembrane bound protein thought to assist the cell with adhesion. 
Considering this purpose, it may make sense that the cell would reduce production of it when under shear 
stress. Reducing MUC15 would essentially downplay the stressful effects that this mechanical stimulus 
would have on the exterior of the cell while simultaneously setting the stage for ease of exfoliation from 
the primary tumor into the ascites. This hypothesis will be further investigated in future research.  
5.5  Future directions  
The future directions of this study include the induced over and under expression of MUC15 in OVCAR3 
cells via lentiviral transduction. Cellular phenotypic changes will be monitored for MUC15 influence under 
control conditions as well as shear stress stimulus. Additionally, assessment of this altered MUC15 
expression on chemoresistance under shear stress will elucidate its true impact as a prognostic factor for 
ovarian cancer patients.  Finally, cell extraction from the 3D hydrogel construct will be optimized and 
analysis of tumor forming ability in xenograft models well be repeated for stimulated and non-stimulated 
OVCAR3 cells.  
5.6  Conclusion 
In conclusion a shear stress bioreactor system, capable of 3D shear stress stimulus was utilized to investigate 
the impact of ascitic fluid movement on ovarian cancer cellular phenotypes. OVCAR3 and OVSAHO high 
grade serious ovarian cancer cell lines were subjected to 1, 5, and 11 dynes/cm2 of shear stress stimulus for 
24 hours. Immunohistochemistry staining showed an increase in proliferation potential under shear stress 
as well as morphological elongation and enhancement of cellular area indicating invasive potential. Slight 
chemoresistance was observed with shear stress stimulus although this was not consistent across cell types. 
Uniform and consistent downregulation of transmembrane glycoprotein MUC15 was found in response to 
shear stress stimulus. In vivo studies for tumor formation and growth rates were inconclusive. Overall, the 




mechanotransduction. Results point towards shear stress as one mechanism that aids in the progression and 
proliferation of the ovarian cancer disease and MUC15 regulation may be a promising protein of interest 






CHAPTER 6: Conclusions and Future Directions
6.1  Contributions to the Field of Cancer Mechanotransduction  
Mechanical stimulus is an influential component to the tumor microenvironment. How cells interpret and 
translate their physical surroundings can determine cell fate and phenotypic expression. These 
mechanotransduction responses can therefore impact patient outcomes by influencing amenability to drug 
treatments. Only by studying this dynamic interaction can we better understand the tumor 
microenvironment as a whole and develop more effective patient treatments. 
6.1.1  Shear Stress Activation of PLAU Pathway in Breast Cancer 
Previous studies have correlated breast cancer and PLAU expression with patient prognosis230 though the 
driver for this association is unknown167.  Through the use of the shear stress bioreactor, our work has been 
the first to tie breast cancer shear stress mechanotransduction and PLAU expression. Within this study, 
shear stress stimulus was found to enhance invasive potential through morphological elongation and 
increased cell area. Proliferation and chemoresistance to paclitaxel were increased with 5.4 dynes/cm2 of 
shear stress stimulus and enzymatic activity of uPA was significantly increased in cellular medium 





Figure 22: Breast cancer shear stress summary of findings. 
 
6.1.2  COX2 Activation via Shear Stress Stimulus in Breast Cancer 
Breast cancer mechanotransduction has been linked to COX2 expression once before by Yoon et al.161. 
However, this was in response to matrix stiffness and a measure of traction forces produced by breast cancer 
cells via Fourier transform traction microscopy. Here, for the first time, we demonstrate the association of 
shear stress stimulus on COX2 regulation in breast cancer cells exposed to 3.0 and 3.25 dynes/cm2. The 
response of the MCF7 cell line after 24 hours of stimulation revealed consistency with the 72 hour studies 
in that both PLAU and the PLAU inhibitor, Serpine 1, expression levels were elevated. However, at the 72 
hour mark MCF7 cells did not maintain this elevated expression as was found in MDA-MB-231 and MDA-




COX2 expression at 24 hours was found to respond effectively to inhibitor treatment with celecoxib. 
Moreover, invasive potential, proliferative potential, and chemoresistance were maintained at this time 
point and for both shear stress values.   
6.1.3  Compression Modulated Activation of CDC42 in Ovarian Cancer 
The study of ovarian cancer mechanotransduction is largely neglected for compressive stimulus. Therefore, 
this work marks the second reported study in this area. The association of CDC42 to mechanotransduction 
is not new however, in that integrin signaling pathways have been shown to activate CDC42 for filopodia 
formation231.  This is the first reported association of compressive mechanotransduction acting through 
CDC42 to enhance ovarian cancer invasive potential, proliferation, and chemoresistance. Further, this study 
supports the argument for CDC42 inhibitor treatment of patients in duality with their chemotherapy, a 
hypothesis that has been proposed many times in the past despite no clinical trials195,212.  
6.1.4 MUC15 regulation in ovarian cancer via shear stress stimulus 
Our research into shear stress stimulus on ovarian cancer has been preceded by a number of investigative 
studies. The lack of stimulus magnitude investigated as well as dimensionality of culture limits the 
translatability of these previous findings. Use of the shear stress bioreactor has enabled us to investigate the 
full breadth of shear force predicted to occur within the ovarian cancer microenvironment while maintaining 
three dimensionality. This is the first reported tie between shear stress and MUC15 regulation though this 
work is ongoing and its role in the observed invasive potential, proliferation increase, and chemoresistance 
tendency remains unclear. This is a promising avenue for continued research due to the evidence in MUC15 
dysregulation in other cancer cell type and the lack of studies concerning MUC15 and ovarian cancer.    
6.2  Future Directions 
6.2.1  Stiffness Modulation with Mechanical Stimulation 
The ECM stiffness has been found to alter the behavior of cancer cells. This has been widely 




been found to increase metastasis, however, there is a discrepancy with OC cells135,236. Some studies show 
ovarian cancer to have enhanced migration, proliferation, chemoresistance, magnitude of traction forces, 
and morphological elongation indicative of epithelial to mesenchymal transition (EMT) when cultured on 
softer substrates135,237, whereas others demonstrate spreading, focal adhesion formation, and traction forces 
increase on stiffer matricies238.  
To address this discrepancy in findings the agarose-collagen system could be used to study stiffness 
effects on ovarian cancer response. Alterations in the agarose concentration would define the stiffness of 
the ECM and collagen dispersion throughout the gel would provide adhesive proteins in a controlled 
manner, reducing potential synergistic signaling from excess collagen concentrations. This study of 
stiffness influence could be further tested in combination with stress from either the shear or compression 
bioreactor, providing a two-variable system for examination. Ovarian cancer response under stiffness 
modulation should be explored first in the agarose/collagen system to establish baseline responses at various 
percentages of agarose. Ideally these stiffness values would replicate the ECM environment found in the 
peritoneal cavity although this would be highly variable depending on the stage and location of the tumor. 
Next, cellular responses within the variable hydrogel composites should be studied under compression and 
shear stress independently. According to our current knowledge, cell response differs little between static 
and cyclic compressive stimulus, thus it is advised that initial investigations focus on static compression 
representative of the solid tumor microenvironment. Within either the compression or shear stress 
bioreactor, structural integrity of the gel should be considered when choosing magnitude of experimental 
stimulus.  How these two mechanical aspects of the tumor microenvironment work together to influence 
cellular response would provide a more complete understanding of the disease.  
6.2.2  Combinatory Stimulation of Shear and Compressive Stress 
Future mechanotransduction studies could include the assessment of combinatory stresses that typically 
occur simultaneously in vivo. To study the combined effects of shear and compressive stimulus a new 




consideration of each component of the tumor microenvironment research findings should approach in vivo 
results and begin to eliminate the need for animal models.  
6.2.3  The Interplay of Cell Types Under Mechanical Stimulus 
It is well known that cells do not exist in isolation. Rather they are surrounded and communicate with a 
diverse population of cell types and signaling factors within their microenvironment. Considering the 
multicellular species that exist and contribute to the tumor microenvironment would be a next step toward 
fully understanding the physiological response to mechanical stimulus. To accomplish this, cell species 
such as differentially activated macrophages or any component of the immune system (Figure 23) could be 
cultured along with the ovarian cancer cells. Additionally, culture methods such as spheroid formation via 
hanging drop or well bottom arrays could combine cell types in an organoid structure prior to stimulation. 
This would enable cell-cell interactions (Figure 24) and include the 3D assembly found in vivo. Taking it 
one step further, excised tumors form murine models could also be encapsulated within hydrogel and 
mechanically sheared or compressed. This could provide the full range of complementary cell types as well 
as the native ECM within the tumor microenvironment while emphasizing the response to a single stimulus 
type for further study. The capability for culture modifications and tunable stress ranges makes the shear 






Figure 23: Immune cell interactions within the tumor microenvironment 
The immune microenvironment of tumors contains cellular components from both the innate and adaptive 
immune systems, with functional immuno-modulation between all the different cell types. Macrophages 
are typically the most abundant population of leukocytes within the TME, derived from both tissue-resident 
and circulating monocytic progenitors. The accumulation of tumor-associated macrophages 
is often correlated with the development of pathological phenotypes in cancer, which leads to the promotion 
of angiogenesis, metastasis, chemoresistance and functional suppression of adaptive immunity. The TME 
counterbalances activating natural killer (NK) cell signals with strong inhibitory signals to escape NK cell 
mediated immune surveillance and further reduce the phagocytic activity of NK cells. NK cells also 
exhibit functional anergic phenotypes with reduced phagocytosis and reduced amounts of cytoplasmic 
granules that contribute to tumor progression. Other granulocytes within the TME often recruited from 
circulating vasculature include neutrophils, basophils, eosinophils and mast cells. Tumors often experience 




vascular normalization and stromal remodeling. Analysis of several solid tumors also indicate that they are 
infiltrated with T-cells and B-cells, recruited from circulating blood and lymphatic structures. The number 
of infiltrated T-cells offer significant prognostic value to cancers. However, the TME reprograms T-cells 
into an exhausted anergic state, leading to severe immune suppression, specifically of the Th and CTL 
(CD8+ cytotoxic T lymphocytes) phenotypes. Additionally, recruited naive T-cells are also converted to an 
insidious regulatory Treg phenotype, which contributes to suppressive immunomodulation. B-cells 
typically respond to tumor-derived antigens and elicit antibody responses through IgM secretion and direct 
stimulation of Th cells. Tumor-educated B-cells are immuno-suppressive, promote regulatory T-cells, and 
promote carcinogenesis. Myeloid derived suppressor cells are heterogeneous mixes of immature myeloid 
cells, found accumulated in lymphoid structures, blood, and the TME, and are heavily correlated with 
immune suppression. Myeloid derived suppressor cells are powerful inactivators of T-cells. Impaired 
myeloid differentiation also results in defective antigen presentation. Coupled with dysregulated T-cell 
priming by antigen presenters like dendritic cells, an overall immune suppressive landscape leads to tumor 
escape from immune surveillance. 
 
 
Figure 24: Cell-cell interactions within the tumor microenvironment 
Various cell-cell interactions within the cancer-organ system. Interactions of cancer and malignant cells 
with their surroundings help dictate their survival and phenotypes. Within the homeostatic non-
transformed microenvironment, various cell-cell junctions are formed ensuring the proper polarization, 
orientation, and proliferation of the non-malignant cells. Cell-ECM interactions provide structure and 
mechanical stimuli to the cellular surroundings through points of adhesion. These native interactions are 
disrupted by the infiltrating cancer cells which interrupt cell-cell communications and displace healthy 
tissue. The cancer cells undergo the epithelial-mesenchymal transition in order to metastasize and do not 
experience the same proliferative inhibition provided by non-malignant cell-cell communication. Well 
established communication between cancerous cells increases survival by avoiding anoikis and promoting 
chemoresistance. Finally, the surrounding ECM, which is stiffened by the presence of the expanding 
cancer mass, aids in additional cancer cell migration, and an altered mechanical environment will feed 




6.3  Conclusion 
My research over the course of my PhD has focused on the development, construction, validation, and use 
of bioreactors for mechanotransduction studies on cancer. Shear stress and compression forces were found 
to heavily influence breast and ovarian cancer phenotypes including invasive potential, levels of 
proliferation, and cell death response to chemotherapeutics through a variety of mechanisms. While the 
ideal cancer model system would incorporate all aspects of the 3D tumor microenvironment, the baseline 
understanding of each mechanical stimulus is equally important to painting the full picture of cancer 
progression. This work contributes to the mechanotransduction field by identifying new associations 
between cellular pathways and shear or compressive stimulus while providing new model systems in which 
to investigate these forces. The success of these projects has been largely dependent on the composition of 













Supplemental Figure 1: 3D and 2D simulation mesh analysis shows independence of solution to mesh 
size. 
A. 3D model mesh analysis shows resultant flow velocity is 3.83 mm s
-1
 and is independent of the 
number of mesh elements. Element type utilized was free tetrahedral.  
B. 2D model mesh analysis shows resultant maximum viscous shear stress on a cell is 5.5 dynes cm
-
2
. This result is independent of the number of elements within the model mesh. Element type is free 
tetrahedral.   
C. Velocity plot through vertical position of hydrogel stack. Velocity magnitude through the center of 
the stack was 3.58 mm s
-1







Supplemental Figure 2: Control 3D IPN Hydrogel did not Demonstrate Oxygen Gradients. 
A. Half geometry of a 2D cross section of control 3D IPN gel.  
B. Simulation of oxygen consumption in MDA-MB-231 embedded IPN control gel after 72 hours, 
showing a maximum oxygen concentration of 0.212 mol m
-3
 at the surface of the gel and an oxygen 
concentration of 0.173 mol m
-3
 at its center. 
  
No Hypoxia in Static Control 3D IPN hydrogel: To show hypoxia was avoided in both shear simulated 
and unstimulated conditions, models of breast-cancer-embedded 3D control gels and 3D shear stressed IPN 
gels were analyzed. The cell line MDA-MB-231 was used in the following numerical models. We assumed 
the concentration of O
2
 in the medium to be 0.21162 mol m
-3
,[66] the concentration of O
2
 in the Incubator 
to be 7.03588 mol m
-3
,[66] the diffusion rate of O
2






,[67] and the average 
O
2






Unstimulated 3D Control Gel: A 2D computational model was constructed using COMSOL Multiphysics 
5.3 to show a time-dependent depletion of oxygen within the non-stimulated 3D control gels. A 2D cross 
section of the plated gel was simulated using the axis of symmetry and 2D revolution tools. The final 
geometry used is shown in Supplemental Figure 2A. The model was run through a transport of diluted 




+ ∇ ∙ (−Di∇ci) + u ∙ ∇ci = Ri                        (8) 
Ni = −Di∇ci + uci           (9) 
ci = coi                                                                 (10) 
Equation S8 and S9 describe diffusion by Fick’s Law, convection and chemical reaction rate constant 
accounting for the cellular consumption of oxygen within the model. In this model it is assumed that the 
surface of gel exposed to the medium will have maximum O
2




concentration given to the surface of the gel in the model. The surface concentration of O
2
 after 72 hours 
(Supplemental Figure 2B) shows that cells furthest from the gel’s surface will be exposed to 82% of typical 
levels of O
2
 present in saturated medium. 
  
No Hypoxia in the Shear Stress Stimulated 3D IPN Gels: The 3D IPN gels plated within the shear 
bioreactor are assumed to be in an airtight, closed system. We assume each gel is equally perfused with 
medium over 72 hours. As the medium in the reservoir is continuously mixing, we assume that every cell 
has equal access to all oxygen in the medium at all times. As such a simple conservation of mass equation 
was used to determine levels of O2 in the bioreactor after 72 hours. The equilibrium between the air and 
the medium nor the rate at which oxygen dissolves into the medium was considered in this equation. The 
medium reservoir contains 160 mL of medium and 840 mL of air. After 72 hours a final O
2
 concentration 
of 5.5956 mol m
-3
 was found within the system, we conclude that it is unlikely for hypoxia to occur within 




Supplemental Figure 3: Optimization of uPA Activity Assay. 
A. Change in absorbance over time for the standard curve of the rehydrated uPA positive control and 
chromogenic substrate.  
B. Linear regressions of absorbance in the standard curve of rehydrated uPA positive control and 
chromogenic substrate, at an incubation period of 2 and 21 hours respectively, where a 2-hour 
incubation shows higher linearity in the proposed AU working range.  
  
Optimization of uPA Activity Assay: A short incubation period is required for the reaction of activated 
uPA with CHEMICON’s chromogenic substrate. A time dependent test was run on a standard curve using 
rehydrated uPA enzyme to determine the change in absorbance over time at varying levels of uPA activity, 
as described in Supplemental Figure 3A. Preliminary data suggested that medium in stimulated gel 
experiments had activity ranging from 1 to 5 AU. Linear regressions were performed on a working range 
of 0 to 20 activity units to determine an incubation period most suited for normalizing experimental 
absorbance readings to the uPA-positive-control’s standard curves, as shown in Supplemental Figure 3B. 






Supplemental Figure 4: Shear Stress Induced Increase in Perimeter, Circularity, and Aspect Ratio. 
A. Perimeter of cells was quantified using image J and all cell types showed a significant increase in 
perimeter when subjected to shear stress (****p< 0.0001, n≥3 experiments).  
B. Circularity of MDA-MB-231 and MCF7 cells under shear stress showed a significant reduction in 
circularity (**p< 0.01, ****p< 0.0001, n≥3 experiments) where MDA-MB-468 cells showed a 
decrease in circularity that was not statistically significant. C) All cell types showed a significant 







Supplemental Figure 5: Shear Stress Decreases Cell Death Due to Chemotherapy Treatment. 
A. Summary of cell death quantification for all experimental conditions and cell types. All results were 
normalized to the control average of the respective cell line. Enhanced cell death is seen under drug 
treated control conditions and a significant reduction in drug induced cell death is shown under 
shear stress stimulation.  
B. Summary of proliferation for all experimental conditions and cell types. A significant enhancement 
in proliferative capability is found for all shear conditions and this enhancement is maintained with 








Supplemental Figure 6: Shear stress bioreactor schematic and computational modeling results. 
A. Overall schematic of bioreactor model rendered in COMSOL Multiphysics. Description of slices 
and/or lines used to determine velocity magnitude.  
B. Plot of the 5mm rod insert velocity magnitude along inner diameter of cell laden IPN hydrogel at 
center of gel and mesh analysis graph for primary COMSOL model.  
C. Example result of the second COMSOL model. Fluid velocity, determined in the first model 
(supplemental Fig. 1a,b) is applied over a spherical cell and resulting shear stress on the surface is 
determined. Units are dyne/cm
2
.  
D. Plot of resulting shear stress around perimeter of cell within the flow field demonstrated in 
supplemental Fig. 3c for high shear. Shear stress experienced by the cell is reported as the maximum 
value, 3.25 dyne/cm
2
 resulting from 5 mm rod inserts and 3.04 dyne/cm
2









Supplemental Figure 7: Compression bioreactor system layout. 






























Supplemental Figure 11: 72hr proliferation and cell death response of OVCAR3 cells under compressive 
stimulus. 
 
Supplemental Figure 12: G-Lisa analysis of CDC42 activation under compressive stimulus and in 
response to inhibitor treatment. 
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Supplemental Table 1: Changes in gene regulation via RT-qPCR analysis. 
Gene Static Cyclic Static Cyclic
ABCB1 1.68 2.98 1.83 3.44
ABCG2 1.30 1.23 1.29 1.14
ALDH1A1 1.46 0.85 0.85 0.93
ARH Gap35 1.24 0.90 4.28 1.66
BCL2 1.37 0.90 1.15 0.72
BMI-1 1.06 0.88 1.14 1.00
CAV1 1.09 1.02 0.93 0.83
CD117 0.84 0.87 2.00 3.94
CD24 1.06 0.90 1.26 0.71
CD90 1.32 1.08 1.05 0.84
CDC42 1.95 2.60 2.66 3.04
c-Src 1.30 0.84 5.64 1.70
E-cad 1.42 0.77 1.48 0.88
HIC1 0.89 0.93 2.51 0.69
MapK1 1.04 1.01 0.67 1.06
MMP1 1.18 0.96 2.59 1.12
MMP14 1.04 0.79 0.96 0.65
MMP9 0.88 0.91 0.77 0.56
NanOg 1.57 1.00 1.23 0.54
N-cad 1.33 0.86 1.23 0.96
OCT4 4.14 0.90 2.10 0.72
PLAU 1.18 1.02 1.18 0.90
PROM1 0.67 1.43 1.05 1.42
PTGS2 1.32 1.27 0.84 1.07
PTK2 0.96 0.92 1.83 0.98
RAC1 1.30 0.99 0.91 1.32
RhoA 1.28 0.91 1.78 2.03
RhoC 1.17 0.92 1.55 1.63
Rock1 1.16 0.87 0.80 0.95
Serpine1 1.14 0.97 1.15 0.97
Taz 1.26 1.11 0.88 0.89








Supplemental Figure 13: Morphological response of ovarian cancer cells with chemotherapeutic drugs 








Gene 11 Dyne 5 Dyne 1 Dyne 11 Dyne 5 Dyne 1 Dyne
ACTB 1.23 1.17 0.99 1.02 1.06 0.99
ANKRD37 1.05 0.66 1.33 1.78 0.92 1.51
B3GNT4 1.01 0.70 1.87 1.12 1.13 1.04
COL20A 0.34 0.75 1.03 0.49 0.55 0.75
DHRS13 0.77 0.51 1.07 1.22 0.95 0.98
FAM71F2 0.43 0.87 1.22 0.58 0.42 0.50
GAPDH 0.87 0.88 1.31 1.11 0.97 1.02
GDF5 0.39 0.88 1.26 0.65 0.70 0.78
LOX 0.91 0.68 1.59 2.60 2.35 2.06
MSANDT1 0.38 0.76 1.04 0.59 0.52 1.12
MUC15 0.28 0.24 0.48 0.42 0.39 0.40
S100A-10 0.97 0.74 1.45 1.87 1.92 1.74
SPON2 1.64 1.29 1.74 0.97 0.82 0.68
TEX29 0.37 0.93 1.41 0.59 0.47 0.86
ABCB1 0.68 0.97 2.21 0.51 0.72 0.95
ABCG2 1.19 0.63 1.10 0.70 0.86 0.78
ARH Gap35 0.82 0.73 0.98 0.66 0.85 0.96
BCL2 0.86 1.20 1.26 0.84 0.84 0.98
CAV1 0.90 0.84 1.09 1.01 1.07 1.66
CDC42 1.16 1.35 1.72 1.21 1.14 0.91
c-Src 1.09 1.24 1.12 1.13 1.14 1.20
E-cad 0.33 1.00 0.81 0.48 0.54 1.06
HIC1 1.10 1.47 1.07 1.80 1.72 1.36
MapK1 0.91 0.77 1.00 0.79 0.82 0.98
MMP1 0.71 1.08 0.97 1.48 1.16 2.05
MMP9 0.94 1.32 0.89 3.37 3.79 3.99
N-cad 0.43 1.26 1.14 0.55 0.65 0.87
PLAU 0.59 0.51 0.77 0.96 0.72 0.93
PTGS2 0.89 0.65 0.83 1.02 1.29 1.42
PTK2 0.72 0.67 0.91 0.78 0.74 0.90
RAC1 0.97 1.06 1.01 0.96 0.93 1.04
RhoA 0.91 0.90 1.02 0.87 0.93 1.15
RhoC 1.22 1.20 0.94 0.98 1.11 1.17
Rock1 0.95 1.36 1.09 0.89 0.99 1.36
Serpine1 1.20 1.34 2.05 1.30 0.87 2.45
4-Oct 0.32 1.13 0.85 0.56 0.81 0.58
ALDH1A1 0.43 0.62 0.74 0.47 0.61 0.60
BMI-1 0.65 0.96 0.84 0.55 0.68 0.81
CD117 0.62 0.39 1.05 0.71 0.81 0.59
CD24 0.65 0.66 0.88 0.23 0.34 0.99
CD90 0.57 0.44 0.78 0.79 0.36 0.59
NanOg 0.50 5.65 1.62 0.38 0.44 0.54
PROM1 0.59 0.61 0.76 0.94 1.21 0.79
Taz 0.49 0.57 0.92 0.64 0.63 0.66






Supplemental Figure 14:  Shear stress bioreactor schematic, mesh analysis, and experimental pump 
settings. 
A. Depiction of modifications made to shear stress bioreactor. Flow path of cell culture medium is 
demonstrated by the blue arrows. 
B. Mesh analysis of the primary COMSOL model. 






Supplemental Figure 15: Morphological analysis of cellular perimeter, circularity, and roundness under 
shear stress stimulus. 
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